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INTRODUCTION
In the constant attempts by the medicinal chemist to increase the 
efficacy of our ever expanding armamentarium of organic medicinal agents, 
the correlation between structure and physiological activity is assum­
ing an ever increasing importance. Thus, in the various groups of drugs 
such as the sulphanilamide derivatives, the barbiturates, the arsenlcals, 
etc. have such studies resulted In the development of new and superior 
compounds•
To date, perhaps in no field is it possible to correlate better the 
effect of chemical structure and physiological activity than in the case 
of the pressor amines. Immediate interest in these compounds was stimu­
lated by the synthesis of epinephrine by Stolz in 1904 (1), with the result 
that a large number of related compounds have been synthesized and their 
physiological properties studied. Loewi and Meyer (2) working with a 
series of ketones of the general formula (i) and the related secondary al­
cohols (II), including epinephrine (III), found that the reduction of the 
ketone to the alcohol greatly intensified the epinephrine-like action, 
which is possessed in some degree by most of these amines. These results 
were confirmed by Dakin (5) in a similar series. Since all the bases which 
he examined were catechol derivatives, he was led to the conclusion that 
it was the catechol nucleus in epinephrine which was the group responsible
OH OH OH
(i) (i d  (h i )
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for its activity* A further basis of this view was the observation that 
catechol itself on intravenous injection raised blood pressure, while 
N-methylaminoethanol (the detached side chain of epinephrine) was with­
out such effect. Barger and Dale, having previously noticed that certain 
amines which were produced by putrefaction and which did not contain a 
catechol nucleus also had an epinephrine-like action, considered this con­
cept inadequate. Thus, they initiated an investigation upon a series of 
amines intermediate between the putrefactive amines, in particular p-hydroxy 
phenylethylamine, and epinephrine itself. This work resulted in their 
classical paper (4) which appeared in 1910 and which will be referred to 
in the following discussion.
Dating from this report, a vast amount of pharmacologic data have been 
accumulated with the result that at present a number of well defined gen­
eralizations may be made concerning the effects produced upon the physio­
logical properties of the pressor amines by various alterations in their 
structure.
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REVIEW OF THE RELATIONSHIP BETWEEN CHEMICAL STRUCTURE AND PHYSIOLOGICAL 
ACTIVITY OF THE SYMPATHOMIMETIC AMINES
I« Sympathomimicity and Pharmacodynamic Classification 
of the Sympathomimetic Amines
Barger and Dale (4) proposed to call the pressor amines which they 
has studied, and which simulate the effects of sympathetic nerve stimu­
lation with varying Intensity and precision, w sympathomimetic .n Although 
this term was wider and more descriptive than the previously used *adrenine- 
like,'"and seemed to indicate the type of action common to these bases, it 
did not involve any theoretical preconception as to the type of relation­
ship to sympathetic action or to the precise mechanism of action. More­
over, these investigators also recognized the fact that pressor activity, 
though a convenient index of sympathomimetic action, is not in itself adequate 
classification* At least some of the other sympathetic nerve effects must 
be observed before a drug can be classified properly as sympathomimetic.
They considered that the association of a pressor action, due to arterial 
constriction and cardiac acceleration, together with inhibition of the tone 
and rhythm of the isolated nonpregnant cat uterus as sufficient evidence 
of sympathomimetic action. These two criteria were used as a basis of their 
classification.
Although the term sympathomimetic is still frequently applied to these 
compounds as a class, no special significance should be attached to this 
term with reference to the mechanism of pressor action, since Tainter and 
his associates (5,8,15,17,20) have shown that a large number of the pressor 
amines, especially those which do not contain the catechol nucleus, do not 
produce their effects by pure sympathetic stimulation. Therefore, the
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phrase wsympathomimetic drug* more properly indicates a compound whose 
action mimics the result of sympathetic nerve stimulation without nec­
essarily acting upon sympathetic innervations# It is thus apparent that 
a "better classification would be one based upon more accurate information 
concerning the mechanism of action of the pressor drugs# Such an improved 
classification has been used by Tainter (15) and is based on the results 
obtained by pharmacodynamic analysis, using the complimentary procedure of 
ergotaminization and cocainization. These procedures were developed by 
Tainter as a result of observations which he and other investigators had made*
Dale (45) discovered that ergot paralyzes the sympathetic motor nerves 
and reverses the pressor action of epinephrine to depressor. Van Dyke (14) 
as the result of experiments performed on the change of the volume of the 
nasal cavity produced by sympathetic stimulation before and after ergo- 
toxine supports Daleys view (13) that the epinephrine reversal Is due to 
unparalyzed vasodilator nerves#
Tainter and Chang (5) first observed that otherwise ineffective doses 
of cocaine prevent the blood pressure rise of tyramine in rabbits, cats, 
and dogs, while It increases the rise produced by epinephrine, the latter 
observation having first been made by Froelich and Loewi (6 ) • This im­
mediately suggested a difference in the mechanism by which these two drugs 
produce their pressor effects. Tainter (7) found that this cocaine sen- 
sitization-desensitization phenomenon appeared to be specific for cocaine 
since it did not occur with other local anesthetics.i
iprocaine has also been stated to sensitize the pressor activity 
of epinephrine (47). Moller (46) found that although procaine produced 
a small augmentation of pressor effect in Intact rabbits, it has no such 
effect in the perfused isolated rabbit ear. From this he concluded that 
the effect of procaine is not peripheral and produces its sensitization 
of epinephrine in intact animals by inhibiting the vasomotor reflexes 
originating in the carotid sinus.
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Subsequently he found that phenylethanolamlne (8 ), ephedrine (9), and 
synephrine (10), as well as a number of other amines (15) are all similar 
to tyramine with respect to their behavior in cocainized animals, whereas 
compounds which contain the catechol nucleus (7,11,12) behave like epin­
ephrine in that their pressor responses are increased by cocaine. Further­
more, cocaine administered subcutaneously to rabbits increases the hyper­
glycemic effect of epinephrine (7,48) but does not sensitize the responses 
of the tyramine-ephedrine group (7)• Thus cocaine produces its effect 
even in functions not involving smooth muscle responses.
This difference in the effect of cocaine upon the pressor action of 
epinephrine and on that of pressors like tyramine suggested its possible 
use in analyzing drug action, i.e., in determining whether or not the drug 
acted similarly to epinephrine (true sympathetic stimulant) as indicated 
by an analogous or different effect of cocaine on their actions. Because 
of this possible importance of the cocaine phenomenon^ a number of studies 
concerning its mechanism have been carried out and the following facts 
have afforded several clues to the problem.
(a) The cocaine phenomenon, at least in part, is peripheral and 
not dependent on the central nervous systemj this is indicated by the 
following results: Tainter (9) was able to demonstrate the cocaine
sensitization-desensitization in decerebrated and pithed cats, in 
cats under different types of anesthesia regardless of the form of 
anesthesia, as well as in the absence of anesthetics. Further evi­
dence is its demonstration in certain isolated organs and tissues.
Thus cocaine increases the action of epinephrine and diminishes or 
abolishes that of tyramine and ephedrine on the heart (heart lung 
preparation) of the dog and on perfused blood vessels of the hind 
limbs (49). Moller (46) has shown that low concentrations of cocaine
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which do not alone produce vasoconstriction in the perfused isolated 
rabbit ear, augment the constrictor effect of epinephrine by 50 to 
300$. Additionally, electrocardiographic studies (50) on anesthetized 
dogs showed that the small doses of cocaine required to produce its 
effect in modifying pressor actions produce no significant alterations 
in the conduction system or muscle of the heart5 this therefore rel­
egates its site of action to more peripheral structures.
(b) Removal of the adrenals from cats does not decrease cocaine sen­
sitization (46). Therefore, the suprarenals have no bearing on this 
sensitization.
(c) Studies with several oxidative enzyme systems showed that cocaine 
does not alter pressor responses by interfering with the oxidative 
processes of the sympathetic endings or of smooth muscle (7).
(d) Since it is known that the degree of pressor response to epin­
ephrine is altered by pH changes of the blood, this factor was con­
sidered. Tainter (12) using cats, was able to show that the pH of the 
blood did not change after cocainization, and hence pH changes are not 
the basis of altered pressor responses caused by cocaine.
(e) It was observed that section and degeneration of sympathetic 
nerves to the iris, heart, blood vessels, etc. result in sensitization 
to epinephrine. Hence, cocaine, if it blocked the sympathetic end­
ings, might account, on a similar basis, for the sensitized responses 
of epinephrine. In studying this possibility, Tainter (12), found 
that the pressor responses elicited by electrical stimulation of 
splanchnic nerves in adrenalectomized cats is not diminished by cocaine, 
thus indicating that cocaine does not block the splanchnic nerves.
(f) Cocaine does not augment epinephrine responses by stimulating
the central nervous system since Burn and Tainter (49) have demonstrated
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that it does not inhibit isolated intestine and virgin cat uterus, 
does not stimulate isolated auricles, and has a dilator action on 
blood vessels#
(g) Swanson (51) postulated that cocaine acts on muscle since he 
found that it abolishes the bronchoconstrictor action of morphine 
and diethylmorphine, which stimulate bronchial muscle. However 
Tainter (7) found that papaverine, a muscle depressant, does not 
alter the pressor responses of epinephrine and tyramine. Thus 
smooth muscle depression per se can not be advanced as an explanation 
of cocaine action.
(h) The possibility that cocaine paralyzes vasodilators and hence 
increases epinephrine responses has also been investigated (US). Sen­
sitization in excised tissues, particularly the heart, where vasodi­
lators can scarcely play a part argues against such a mechanism. 
Moreover, after cocaine sensitization has been produced in the intact 
animal, ergotamine still causes a typical epinephrine reversal in the 
same animal, indicating that the vasodilators are still functioning.
In addition, the depressor action of 5,4 dihydroxy-homoethylnorepin- 
ephrine (15) also furnishes evidence that the activity of the vasodi­
lators is not altered by cocaine, nor by ergotamine, since these two 
drugs do not modify the depressor action of that amine.
(i) Burn and Tainter (49) observed that denervation of the pupil of 
the cat eye sensitizes it to epinephrine while abolishing the effect 
of tyramine. From this they suggested that epinephrine acts, in part 
at least, by stimulating the myoneural junction, whereas tyramine 
acts on sympathetic nerve endings which are destroyed by denervation; 
therefore cocaine probably increases epinephrine action by altering 
the myroneural junctions, and decreases tyramine action by depressing
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sympathetic endings so that they are less easily stimulated but their 
conductivity is not decreased.
Though no completely satisfactory explanation of the cocaine phenomenon 
has yet been advanced, the cocainized animal together with the ergotaminized 
animal has afforded a practical pharmacological method which Tainter and 
his associates, as previously stated, have used to classify the sympatho­
mimetic amines.
In the cocainization procedure (15) control pressor responses to the 
amine in question together with the appropriate dose of epinephrine which 
produces about a 50 mm, rise in blood pressure are obtained in urethanized 
cats. Cocaine in doses of 15mg./Kg. is then injected subcutaneously. After 
allowing 15 minutes for absorption, the control- dose of epinephrine is re­
injected. A doubling of the epinephrine’ response indicates adequate co­
cainization and a normal responding cat. .The control dose of the amine in 
question Is reinjected and the response compared with the control response 
of the same amine. If the response of the amine has been sensitized 
(increased) it acts like epinephrinej if the response is decreased, it acts 
differently from epinephrine.
In the ergotaminization procedure (15) control responses to epin­
ephrine and the amine are similarly obtained. Then ergotamine is injected 
intravenously in doses of Img. at a time until the rise of blood pressure 
produced by the control dose of epinephrine is reversed to a fall, indicat­
ing adequate ergotaminization. The amine is then reinjected and its response 
compared with the control. If its response is reversed the amine acts like 
epinephrine.
With these two complimentary procedures, Tainter has subdivided the 
sympathomimetic compounds which he has studied into three groups.
(a) Sympathicotropic. Those compounds which act like epinephrine ly
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stimulating sympathetic innervations* The pressor actions of these 
drugs, like those of epinephrine, are sensitized by cocaine and re­
versed by ergotamine.
(b) Musculotropic * Those compounds which like barium and pitressin 
stimulate muscle directly. Since the pressor responses of barium 
and pitressin are not altered ty cocaine and ergotamine, those drugs 
whose pressor responses are also not altered must act like barium and 
pitressin and accordingly are also musculotropic#
(c) Pseudo—sympathicotropic* Those compounds whose action is in­
definite or intermediate between the other two and which do not com­
pletely satisfy the criteria which establish the first two groups#
In this group are found a large number of compounds such as ephedrine, 
phenylpropanolamine, and tyramine whose pressor mechanisms probably 
do not strictly conform to a single seat of action and concerning 
whose mechanism of action there is still controversy# It is also 
conceivable that as our knowledge of these compounds Increases, it 
may be possible to split this group into several subgroups with more 
clearly defined modes of action*
Tainter (17) has recognized the limitations of this classification in his 
statement that a more complete classification, based on considerations of 
the actions in both cocainized and ergotaminized organisms, will ultimately 
be needed# The simple classification presented above does not suffice to 
catalogue the graduations and combinations of pressor responses on record* 
Until further studies and data are available, speculation on the details 
of the mechanism of action would be premature •
More recently Mulinos and Osborne (5S) have questioned the accuracy 
of Tainterfs method of determining the site of action on the basis that he 
employed intact animals in which reflex and brain stimulations are not easily
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separated from drugs acting peripherally* They asserted that drugs which 
act on sympathetic ganglia and which stimulate the central nervous system 
directly or reflexly may appear to be sympathomimetic in the intact 
animal. In addition the blood pressure rise follovd.ng stimulation of the 
C.N.S. maybe reversed by ergot and augmented by cocaine. For example, the 
reversal of the pressor action of chloracetylcatechol by ergot and its 
augmentation by cocaine would lead to the conclusion, on the basis of 
Tainter t s method, that this drug acts like epinephrine and is sympathico­
tropic, However, their experiments indicated that it raises blood pressure 
by stimulation of the medulla and its action is increased by cocaine only 
if the medulla is intact. Therefore, in order for the criteria of ergot­
amine reversal and cocaine synergism to be applicable for analysis of sym­
pathomimetic activity, these investigators maintain that the experiments 
should be performed on pithed animals. They concluded that in intact 
animals, ergotamine reversal and cocaine synergism indicates only that im- 
pluses eliciting the blood pressure rise reach the blood vessels by way 
of sympathetic nerves, but do not indicate the site of origin of these im- 
pluses.
Bum and Tainter (49) have found that cocaine can depress as well as 
augment epinephrine action in the same tissue (isolated heart) depending 
on how the cocaine is supplied to the heart. This brings up the question as 
to whether it can be concluded that a substance whose action is depressed 
by cocaine therefore does not act on some part of peripheral sympathetic 
mechanism.
II. Optimum Skeleton for Activity
If the structures of the better known naturally occurring pressors 
such as tyramine (IV), epinephrine (III), ephedrine (V) and_p -phenyl-etkyi
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amine (VI) are examined, it is readily apparent that all possess a struc­
tural feature in common; namely, that a phenyl group is attached to a
aH//
IHOH-CHNHCH--CH> Sh2 -CHsNH2  CHOH-CH 3 3  CHe-CH2 NHe
(IV) (V) (VI)
terminal carbon and an amino or substituted amino group to the adjacent 
carbon of an aliphatic chain# Whether or not such an arrangement provides 
maximum activity has been the object of several investigations#
In considering first the aliphatic amines, Barger and Dale (4) in a 
study of a series of twenty-one obtained the following results in cats#
(a) The normal chain compounds are more active than the branched or 
iso chain compounds# Thus isobutylamine was found to be inactive on 
blood pressure in the doses used, and isoamylamine is less active than 
n-amylamine but more active than isobutylamine#
(b) Pressor activity begins with n-butylamine and increases with the 
length of the chain up to six carbon atoms, n-hexylamine being the 
most active. As the chain is increased from six carbon atoms, the 
activity decreases while toxicity increases and makes the study of . 
the higher members difficult due to their depressant heart action.
tkXt
Tainter (15) however found^the n-amylamine is the most active of the 
aliphatic amines#
(c) Primary amines are more active than the corresponding secondary 
and tertiary amines# Thus methylisoamyl^amine is only one half as 
active as isoamylamine#
(d) Introduction of an additional amino group into n-amylamine to 
form cadaverine NH2 CH2 -C3 H6 -CH2 NH2  reverses the pressor action and 
converts it to a depressor one# #
12
The activity of the aliphatic amines in general is best summarized by 
Tainter is statement (15) that their pressor activity is lacking for the 
majority of these compounds or is weak, variable and -unimportant#
Studies of the aromatic portion of the natural pressors have also 
shown that the aromatic group alone does not represent maximum activity# 
Although catechol itself does have some pressor activity according to 
Dakin (3), and Barger and Dale (4), the latter concluded that it had none 
of the other characteristics of sympathomimetic action# Tainter (11) in 
analyzing its pressor action found it to be variable and complex and 
complicated by several side effects which make its blood pressor responses 
difficult to interpret. In his review of the sympathetic compounds,
Hartung (18) states that except for catechol, the aromatic nucleus in it­
self is not sufficient to produce the desired physiological effect al­
though its presence in these compounds is very important#
That the presence of an amino group is essential for optimum activity 
is indicated by the study of several compounds lacking this group# Tainter 
has shown that phenylacetate has no pressor activity (15) while p-ethyl- 
phenol shows only an irregular pressor action in cats with the first in­
jection and depression with a second one (17)#
The relative position of the amino group in relation to the aromatic 
nucleus which produces the most active compounds was established by the 
studies summarized in tables 1 and 2# Barger and Dale (4) from their 
results (table 1 ) concluded that ®the optimum carbon skeleton for sym­
pathomimetic activity consists of a benzene ring with a side chain of two 
carbon atoms, the terminal one bearing the amino group#®
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TABLE 1
Optimism Position of the Amino Group (4)
Amine Pressor Action
1# C6 H5 NH2 None
2# C6 HSCH2 NH2 Trace
5# G6 H5 CHHH-CH3 Trace
4. C6 H5 CH2 -CH2 NH2
Most active of the group# More 
active than the most active ali­
phatic amine#
5# C6 H5 CH2 -CH2 -GH2 NH2 Less active than 4#
Hartung and Munch (21) as well as Tainter (15) studied the pressor 
effects of 4 ^-phenylethylamine and a series of four isomeric phenylpropyl- 
amines# Their results summarized in table 2 show convincingly that the 
optimum activity is obtained when the aryl and amino groups are separated 
by two aliphatic carbons# If the amino group is moved farther from or 
closer to the phenyl group the degree of activity is diminished# Thus any 
further increase in activity must result from the introduction of various 
substituent groups into the molecule# Tainter disagrees with Hartung and 
Munch as to the pressor value of compound 5 (table 2)# Having found this 
amine to be a poor pressor, Tainter adds an additional condition for 
optimum activity— the phenyl group must be on a terminal carbon#
Additional evidence to substantiate the above findings is furnished
14
TABLE 2




















1 . c6 h5 .ch2 .ch2 nh2 450 6 0 good rise 185 1 0
2 . c6 h5 *chhh2 *ch2 .ch3 1 0 0 0 50 slight rise 800 7
5. C6 H5 .CH2 .CHM 2 .CH3 25 25




L* c6 h5 .ch2 .ch2 .ch2 hhs 1 0 0 50 medium 
transitory rise
1471 1 1
C6 H5 .GHCH3 .CH2 m 2 500 50 good pressor 1051 5
by the observation of Baehr and Pick (22), Hasama (25) and Tainter (7).
The former observed that if in hordenine (VII) the diethylamino group is 
removed from the aromatic portion by three or four carbon atoms, the pressor 
potency becomes less. Hasama in comparing the two isomeric phenylethanol- 
amines, C6 H5 CHHH2 .CH2OH and C6 H5 CHOH.CH2 NH2, found the first to have no 
influence on the blood pressure whereas the activity of the second is well 
established (4,8,24). Tainter observed that if the chain separating the 
aromatic nucleus in 3,4-dihydroxyphenylethylamine (VIII) is increased to 
three carbon atoms to produce 3, 4-dihydr oxyphenylpropylamine (IX), the pressor 
activity is diminished by two-thirds.
The introduction of an additional phenyl group produces a deleterious
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effect on pressor activity# Thus 1,2-diphenylethanolamine (x) is purely
depressant on blood pressure as well as on other circulatory functions
(23), and bis-(2-phenylethyl)-amine (XI) also produces a fall of blood
pressure (7).
Ill# Effect of Increasing the Length of the Side Chain
A# Increase to three carbon atoms*
By comparing related compounds containing two and three carbon atoms
in the aliphatic side chain (table 3) several conclusions may be drawn.
The ability to produce a rise in blood pressure is still resident in com­
pounds with a three membered side chain. However, the introduction of a
third carbon into a two carbon side chain, in general, decreases the pressor
activity, has a variable effect on toxicity and confers oral activity.
The propane derivatives produce an effect of longer duration and usually
exhibit tachyphylaxis, i.e. successive doses show decreased pressor effects.
Another important difference between the ethane and propane derivatives is
the ability of the latter to potentiate the pressor response of epinephrine.
Launoy and Nicolle (28) observed that the action of epinephrine was in­
creased after ephedrine. The same phenomenon was also observed by Munch
and Hartung (29) who reported that the ability to potentiate the pressor
action of epinephrine in dogs is characteristic of phenylpropanolamine
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derivatives* When the side chain is increased or decreased from a three
membered one, the compound no longer shows this potentiation effect.
B* Increase beyond three carbon atoms.
The lengthening of the side chain beyond propyl is attended by a
decrease in activity, conversion to a depressor action, and an increase
in toxicity (table 4). Chen, Wu and Henriksen (32) found that in per­
fusion experiments on the frog heart, the increase in the number of carbons
increased the depressant heart action* Moreover, toxicity in rabbits
(intraven.) ran parallel with the depressant action on the heart. They
therefore attribute the lack of pressor action of compounds with long side
chains to their depressant action on the heart. For these reasons, the
most valuable members of the sympathomimetic amines are those containing
side chains of two or three carbon atoms.
A striking difference between the sympathomimetic amines containing
two carbon atoms in the side chain and those containing three is the
ability of the latter to show their pressor effects after oral administra­
tion, a property lacking in the former.
Chen, Wu and Henriksen (32) attributed the oral efficicacy and pro­
longation of the activity of ephedrine (V) and propadrin (XII) to the
presence of the third carbon in their side chains since they found that
phenylethylamine (VI) and phenylethanolamlne (XIII)
IV. Oral Activity and Enzymatic Inactivation
CHOH.CHNHg.CH3 CHOH.CHgNHg
(XII) (XIII)
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1 . c6h 5c h o h.c h n h2,ch3 600 75 Good pressor, l/60 as active as
1 -epinephrine (15)
2. c6h 5o h o h.c h nh2.c2h 5 250 60
Low activity in dogs (35) and pithed cats
(32). 1/2262 activity of 1 -epinephrine in
cats (15)
s, c 6h 5c h o h.c h nh2.c 3h 7 300 40 Depressor in cats (15)
4. C6H5CHOH.CHNHCH3C3H7 35(32) Depressor in cats (15)
5. c6h5choh.chnh2.c4h9 250 2 0
Depressor in cats (15). lOmg./Kg.in dog
caused fall in b, pressure, followed by a
grad, rise to a new level as much above as
the fall was below normal (33)




175 33 3/5th as active as compound 1 (53)
ch3
- 0
c h o h.c h nh2.c2h s




All doses tried (0.05-0.5 mg./Kg.)




c h o h.chnhch3.c2h5
Depressor (31)
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are inactive orally in man#
Piness, Miller and Alles (36) were desirous of determining what phenyl- 
ethanolamine (XIII) lacked structurally to make it orally active. Since 
it differed from ephedrine (V) by a methyl group in the side chain and on 
the amino group, they investigated phenylethylamine (XIV) and two of its 
methyl substituted derivatives (XV) and (XVI) .
A . \IIJ |i 3V  a !\AvCHa•CH2HHg CH2 .CHgHHCH3 CHg.CHKHg.CHg
(XIV) (XV) (XVI)
They found (XIV) and (XV) to be inactive orally, while (XVI) possessed oral 
activity and its action was of greater duration than that of the other two. 
From this they also concluded that it is the methyl group on the side 
chain which is responsible for oral activity.
Hartung et al (21) further substantiated these findings by showing 
that the extension of the side chain of -P -phenylethylamine conferred oral 
activity whether the methyl group is substituted on the or- 0  carbon.
Several groups of investigators have studied the enzymatic inacti­
vation and the fate in the body of a number of pressor amines. Their 
results have further contributed possible explanations of the effect 
of structure on the oral activity, relative toxicity, duration of action, 
etc. of these compounds.
Blaschko (37) showed that there is present in extracts of liver, in­
testine and other tissues of mammals an enzyme which catalyzes the oxidation 
of epinephrine. This enzymatic oxidation in the presence of cyanide (which 
prevents autoxidation and secondary reactions) involves the uptake of one
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atom of oxygen per molecule of epinephrine* Richter (58) then found that
in this oxidation of epinephrine, as well as in that of other related
primary, secondary and tertiary pressor amines containing the amino group
on the end of a two carbon atom side chain, an aldehyde and ammonia or a
lower amine is produced in each case* He therefore explains the oxidative
deamination of epinephrine by the equation,
OH
OH +
+ 1/2 02   ---> I J j +NH3 CH3
H00H.CH0
and that of the other amines studied by analogous reactions. This re­
action is chemically similar to the oxidative deamination of tyramine
which Hare (59) studied and which he found to be catalyzed by an enzyme
present in liver. The results of Weinstein and Manning (41) substantiate
this type of epinephrine oxidation* They found that when epinephrine is
injected into rabbits, an acid with properties similar to protocatechuic
acid is excreted in the urine. Thus under these conditions, the epin­
ephrine also appears to be inactivated by oxidation in the side chain,
possibly by Blaschkois amine oxidase.
On the other hand Richter (6 8 ) found that epinephrine, as well as
corbasil (5,4-(0Il)2 C6 H3 CH0H.CH^2 .CH3) and epinine (3,4-(0H5c6 HjCHs.CHjpCH3) 
are eliminated after oral administration to men chiefly by conjugation
(phenolic ester) instead of by oxidation by amine oxidase. From this he
inferred that conjugation is more rapid than oxidation by amine oxidase
and probably is the main physiological method by which these compounds are
inactivated in the body. He explains the excretion of cate chuic acid
HCOH.CHpNHoCH,
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observed by Weinstein and Manning as due to their heating the rabbit*s 
urine with alkali. Since protocatechuic acid may be formed from epin­
ephrine by heating with alkali, this acid may have been produced from 
epinephrine in the urine,
Blaschko, Richter and Schlossmann (45) studied the relationship of 
structure to inactivation by amine oxidase in vitro in a series of sym­
pathomimetic amines. They were able to show that, (a) certain groups 
which are present in the epinephrine molecule, namely, the hydroxyl in 
the side chain, the phenolic hydroxyls and the N-methyl group are not 
essential for the enzymatic oxidationj (b) only those amines which like 
epinephrine contain the amino group on the terminal carbon of a two membered 
side chain are oxidizedj and (c) those amines which differ from epinephrine 
only in the presence of an additional CH3  group in the side chain are not 
Oxidized, They therefore concluded that the =C-CH2 -N= is essential for the 
oxidation, Further studies by this group of workers (40) on a more ex­
tensive series of sixty-six amines confirmed their previous observation 
that only compounds containing the amino group at the end of the hydro­
carbon chain are oxidized. In the case of ephedrine and other iso- 
propylamine derivatives, their resistance to the action of the enzyme is 
not due to their lack of affinity for the enzyme, since they inhibit the 
oxidation of other amines by competing for the enzyme (competative inhibitors).
In addition to amine oxidase Beyer (44) also studied a second enzyme, 
phenol oxidase. This enzyme was found to catalyze, in vitro, the oxidation 
of compounds containing an isopropylamine side chain when these compounds 
also contain a para phenolic hydroxyl, but not when this group is lacking.
Thus compounds like ephedrine, propadrine and benzedrine which are active 
orally and which contain an isopropylamine side chain, but no phenolic 
hydroxyl, are not inactivated by either amine oxidase or phenol oxidase
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in vitro.
Supplementing these observations are a number of studies conducted 
in vivo. Richter (56) observed the excretion of ephedrine following its 
administration. Beyer and Skinner (55) found that about half a given 
dose of benzedrine is excreted as such by the dog*s kidneys over a period 
of forty-eight hours £ but if kidney function is impaired by CC14, the 
excretion of the drug becomes as much as 100% of the given dose. Ascorbic 
acid also plays a part in the destruction of benzedrine since its feeding 
to dogs reduces the excretion of this amine to about 55% of the controls, 
depending on the vitamin 0 content of the animals (79). Beyer and Lee (80) 
investigated a number of non-phenolic compounds related to benzedrine in 
order to determine whether they are excreted in the urine or totally in­
activated in the body. They found that the compounds in which the amino 
group is not on the terminal carbon atom of the side chain are excreted 
in the urine after oral administration to men. These compounds are also 
not deaminated by amine oxidase in vitro. -P>-phenyl-n-propylamine and 
^-phenyl-n-propylamine, having the amino group on the terminal carbon^ were 
not excreted in more than occasional traces by either humans (orally), or 
by dogs injected subcutaneously in order to rule out the destruction of 
these amines before their absorption into the body. However, the impair­
ment of liver function by CC14  or hydrazine caused these two amines to be 
excreted to some extent, thereby indicating that the liver is a principle 
site of inactivation of these amines whether or not it be entirely by amine 
oxidase •
From their results together with what has been found to be true for 
other similar sympathomimetic amines, Beyer and Lee (80) offer the follow­
ing explanation of oral activity and fate in the body of these agents.
win this particular group of amines the position of the amino
group on the side chain determines whether the compound shall be
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active orally and excreted by the kidneys, or inactive orally and 
totally inactivated in the body enzymically or otherwise# The 
compounds that do not have the amino group on the terminal carbon 
atom are active orally, not because they are not broken down by the 
digestive juices, but because on being taken into the body they are 
not deaminated at once when brought by the portal system to the liver. 
This being the case they are then carried to all parts of the body#
Since they remain in the blood stream, at least to some extent, for 
a long period of time they are cleared from the blood by the kidneys 
and appear in the urine# part of the drug remaining in the tissues 
is inactivated by some system as the ascorbic-dehydroascorbic acid 
system#
H Confirming this interpretation, these compounds having an amino 
group on the terminal carbon atom have no physiological effect when 
taken orally# Also they do not appear in the urine as such even when 
injected subcutaneously# It seems likely then that, administered 
orally, instead of being broken down in the digestive tract the com­
pound is absorbed, deaminated to some extent in the intestinal wall, 
where amine oxidase has been shown to be present, and the rest brought 
to the liver where the enzymatic oxidation is complete#w
Enzymic activity has also figured in several other theories concern­
ing sympathomimetic activity# Gaddum and Kiviatkowski (6 6 ) proposed the 
theory that ephedrine potentiates the action of epinephrine by inhibiting 
amine oxidase and thus preventing the destruction of the epinephrine. This 
is similar to the view that eserine potentiates acetylcholine action by 
inhibiting choline esterase# Likewise the tachyphylaxis of ephedrine may 
be due to the blockage of the motor receptors by ephedrine which thus 
excludes the chemical transmitter through whose preservation from the enzyme 
the earlier doses of ephedrine produce their effect.
Tainter and Morton (67) found that amines containing no catechol nucleus, 
nor a meta phenolic hydroxyl group, show vasoconstriction when perfused 
through the hind legs of cats only if epinephrine is added to the perfusion 
fluid# They therefore proposed the hypothesis that these compounds (such as 
ephedrine and tyramine) produce at least part of their action by blocking 
the enzymes, or other local tissue mechanisms, which inactivate epinephrine. 
They thereby permit increased local concentrations of this hormone liberated 
from the sympathetic endings or derived from the blood stream, which causes 
stimulation#
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V. Effect of the Alcoholic Hydroxyl in the Side Chain
A comparison of similar compounds differing only by a hydroxyl group 
in the side chain indicates that the presence of the alcoholic hydroxyl 
group on the carbon atom bearing the aromatic group generally increasses 
pressor potency and decreases toxicity (table 5).
In addition Chen, Wu and Henriksen (52) claim that this group is 
essential for mydriatic action. Thus £-phenyle thy lamine which is devoid 
of this group has no mydriatic action on the rabbit pupil, while phenyl- 
ethanolamine shows mydriatic action.
VI. Modification of the Primary Amino Group
Among the natural products belonging to the sympathomimetic group can 
be found primary, secondary and tertiary bases. The physiological dif­
ference between these respective types has also been investigated.
Barger and Bale (4) were among the first to study this phase of pressor 
activity. They reported that when-P-phenyle thy lamine (VI), tyramine (IV), 
and phenylethanolamine (XIII) are converted into their corresponding secon­
dary methylated bases there is no appreciable change in pressor potency. 
However in the case of 3,4-dihydroxyphenylethylamine, they found that methyl- 
ation to the secondary amine increases the activity fivefold. Other xvorkers 
have reported that methylation does affect pressor activity. Chen, Wu and 
Henriksen (32) showed that conversion of phenylethanolamine and phenyl- 
butanolamine into their corresponding methylated secondary amines decreased 
pressor action. They stated that except in the case of phenylethanolamine, 
the other primary amines which they studied are less toxic than the corres­
ponding secondary amines. Tainter (15) found that C6 H5 .CH2 .CH2 HHS is 1/83
Table 5
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as active as epinephrine while C6 H5 .CH2 .CH2 NHCH3  acts irregularly in cats, 
producing only depression in two out of five cats,
Tainter (12) has studied the effect of converting epinephrine into 
the corresponding primary amine (arterenol). He states that 1-epin- 
ephrine is 1 . 2  times as active as dl-arterenol on blood pressure in ureth- 
anized cats. However since dl-epinephrine is only l/2 as active as 1-epin­
ephrine, dl-epinephrine is only 2/3 as active as dl-arterenol. Since 
1-epinephrine is 3.3 times as toxic as dl-arterenol and is only 1.2 times 
as active, arterenol has almost 3  times the therapeutic index of 1 -epin­
ephrine. Moreover, the duration of action of arterenol is greater than 
that of an equivalent dose of 1-epinephrine. The removal of the methyl 
group of epinephrine also influences its mechanism of action. Thus though
CHOH.GH2HHCH3 CHOH.CHgWHg
epinephrine arterenol
ergotamine (12) and yohimbine (59) reverse the pressor action of epinephrine, 
they do not reverse that of arterenol.
According to Chen, Wu, and Henriksen (32), the methylation of dl- 
propadrine to produce dl-ephedrine decreases the activity and increases the 
toxicity by about 2 0 $.
CHOH.CHNH2 .CH3  CHOH.CHNHCH3 .CH3
propadrine ephedrine
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Tainter (15) on comparing 3,4-dihydroxypropadrine and 3,4-dihydr oxy- 
ephedrine found that the former is more than three times as active as the 
latter, while Chen and Chen (54) found the activity of the former to be 
ten times as active.
The introduction of a second methyl group to produce a tertiary amine 
works to further disadvantage. Thus hordenine shows a mixed action consist­
ing of a nicotine-like effect, on ganglia and sympathetic stimulation. It 
customarily gives a rise of pressure which is poorly sustained and which 
produces an irregular form of curve (1 0 ) •
OH
hordenine methylephedrine
Methylephedrine has been found to be less active, and more toxic than ephedrine, 
and no longer has a mydriatic action (32)* Curtis (61) states that methyl­
ephedrine is far less active in pithed cats than ephedrine although it still 
dilates the cat bronchi with the same efficiency. Pak and Read (62) found 
that in cats the pressor action of methylephedrine is approximately l/lO 
that of ephedrine but accelerates the heart less; while in moderate doses 
it does not, like ephedrine, stimulate the central nervous system, is less 
toxic in rabbits and dogs, and is still effective by oral administration.
The use of higher alkyl groups in place of methyl is again a step in the 
wrong direction. In the phenylpropanolamine series C6 H5 CHOH-CHNHR.CH3, when 
R=C3 H7 ,C4 H9  or C5 Hl;L the resultant compound has a depressor effect in pithed 
cats, and an increase in toxicity results as R increases from CH3  to 
C5 Hn  (iniraven. in rabbits) (32). Thus when the number of carbon atoms in
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the alkyl group attached to the nitrogen increases beyond two, a depressor 
action becomes the predominate feature and the toxicity in rabbits and the 
depressant action on the frog heart increases.
Barger and Dale (14) observed that the conversion of the amino group 
to a quarternary ammonium salt produces compounds with nicotine-like actions.
Kanao (65) found that if the alkyl group on the nitrogen is suf­
ficiently large, the compound assumes anesthetic properties. Thus 
C6 HsCHOH.OH2M R  is anesthetic when R equals isobutyl or phenyl. 
C6 H5 .CHOH#CHNHR.CH3  is non-anesthetic when R equals ethyl or propyl, but 
is anesthetic when R equals allyl, isobutyl, isoamyl, benzyl, p-amino- 
benzyl, furfuryl or citral.
Chen, Wu and Henriksen (52) have considered alkyl substituents on the 
amino group as a factor in producing mydriasis in the rabbit pupil. They 
observed that if the alkyl groups on the alpha carbon and on the amino 
group is methyl or ethyl, mydriatic action remains. Further lengthening 
of either of these substituents makes this specific action disappear.
Both primary and secondary amines may dilate the pupil, but the formation 
of a tertiary amine abolishes this property.
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PROPADRINE SERIES 
I* Review of propadrine 
Phenylpropanolamine (XVII) Is also known as norephedrine in the
hcoh.chnh2 .ch3
(XVII)
French literature, as propadrine in America, and as mydriatin, the latter 
being the name under which it was patented by Nagai (72) •
It was first isolated from a natural source in 1928 by Smith (75) who 
obtained the d-pseudo isomer from the Ephedra species. In 1950 the 1-isomer 
was obtained by Seizo and Kanao (74) from Ma Huang, and by Wolfes(75) 
from the European Ephedras.
Hirose (76) first observed its pressor effects in animals, and found 
that as a pressor drug it was weaker than dihydroxyphenylethanolamine•
He also observed that the racemic mixture dilated the human and frog pupil. 
Amatsu and Kabota (77) from their work concluded that its action is quan­
titatively the same as that of ephedrine. This was later confirmed by 
Hartung and Munch (21) who found that it is as active as 1-ephedrine, pro­
duces in substantially every respect the characteristic responses of 
ephedrine, is active orally, and when given Intravenously to dogs produces 
a prolonged rise in blood pressure.
1. Classification of action. Tainter (15) observed that in cocainized 
cats, the pressor effects of propadrine are almost completely abolished,
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while those of epinephrine are definitely sensitized# Ergotamine reverses 
the pressor action of epinephrine but completely abolishes that of prop­
adrine without reversing it. From this it follows that propadrine is not 
sympathicotropic since it does not act like epinephrine# lieither is it a 
pure musculotropic stimulant since cocaine and ergotamine do not decrease 
the reactivity of drugs acting purely on muscle# For these reasons prop­
adrine must be classed as a pseudosympathicotropie drug. The abolition 
of its pressor action by ergotamine should not be interpreted as evidence 
that propadrine stimulates the sympathetic vasoconstrictors, but has no 
action on vasodilators since it can be readily seen that this interpretation 
would be inconsistent with the results after cocainization where the vaso­
constrictors are hypersensitive and where the drug is inactive#
This pseudosympathicotropie nature of propadrine was substantiated 
by Levy (78) who worked with cocainized animals and with dogs whose vaso­
constrictor endings were paralyzed by yohimbine# In both instances the 
pressor action of propadrine was only diminished. From these results he 
also concluded that propadrine was not a pure sympathicotropic drug# He 
also concluded that while propadrine could be considered as having both 
sympathicotropic and musculotropic properties, at least as to its point of 
vasomotor site, it is probably more sympathicotropic as shown by the dim­
inution of its pressor action and complete abolition of renal vasoconstrictor 
action after yohimbine, as well as the persistence of pressor effect, though 
diminished, in the cocainized animal#
2. Pressor effects. Various authors agree that propadrine is as 
active as ephedrine on the blood pressure (S3,78,81,30) when injected intra­
venously, and Hartung (SI) reports it to be active orally when given in 
adequate dosage. Intravenously in dogs, its pressor ratio to epinephrine 
has been stated to be about 390 (69) and 250 (78)# In urethanized cats, 
Tainter (15) found that 1 mg./Kg* of racemic propadrine caused a median rise
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of* 2 0 %  which lasted 1 0  minutes, and produced no consistent change in pulse 
rate which he considered suggestive evidence against a sympathicotropic 
action. Its pressor ratio to epinephrine had a median value of 60 in­
dicating it to be more active in cats than that indicated for dogs in the 
above studies. Since in his work an adequate number of animals was used, 
with good agreements between them, he feels that the ratio of 6 0  correctly 
indicates its degree of activity. Though subcutanously or intramuscularly 
1 0  mg. produced a moderate prolonged rise of blood pressure, SO mg. in­
jected into a loop of intestine in situ, produced no rise. It is said to 
exhibit, like ephedrine, tachyphylaxis, i.e., each successive dose pro­
duces a smaller rise in pressure than previous doses (32,78,21,69) though 
Tainter (15) in his experiments on cats observed that two Injections of 
1  mg. spaced one hour apart gave reproducible results.
5. Optical isomers. The six optical isomers of propadrine were sep­
arated by Kanao (82) in 1928. According to Hirose (cited by Chen and
Schmidt - 83) the order of activity of these isomers is as follows: 
d-pseudo ̂  dl=l, d < 1 , d-pseudo > 1 -pseudo 1 .
Chen, Wu, and Henriksen (32) point out that the dl-isomer is a stronger 
pressor than dl-ephedrine and attributes it to the absence of the methyl 
group on the amino nitrogen. The d-pseudo isomer is weaker than the 1 or 
dl-ephedrine, but stronger than the d-pseudo ephedrine. Launoy and Nicolle 
(84) state that racemic propadrine Is more active than racemic ephedrine, 
and that the 1 - form is three times as active as 1 -ephedrine.
4. Cardiac action. Levy (78) reported that in situ, weak doses of
racemic propadrine slowed the heart due to stimulation of the vagus center. 
In the atropinized animal, cardiac stimulation with an Increase In the 
amplitude of auricular and ventricular contractions was observed. With
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larger doses or repeated small doses, cardiac depression with a diminution 
of amplitude was the result; the diminution being transient if the dose is 
small enough, but prolonged and accentuated with stronger doses, giving 
place at times to auricular ventricular fibrillation* 5  eg* injected into 
the lymph sac of frogs stopped the heart in diastole after two hours, while 
a 1 %  solution applied locally slowed the frequency and diminished the 
amplitude* Chen, Wu, and Henricksen (32) found that perfusion of frogs 
hearts produced no increase of heart rate, and 1 :1 ,0 0 0 , 0 0 0  was the minimal 
concentration causing depression* 2 to 5 mg. increased the amplitude of 
the beat of isolated rabbits* auricles (69) though epinephrine produced 
a bigger effect in doses over 1 , 0 0 0  times as small*
In general it may be stated that its cardiac action is stimulating 
in small doses but depressing in larger doses* Its action on the heart 
vessels, as well as on the bronchi and intestine indicate a close re­
lationship to ephedrine.
5* Mydriatic action* Miura (85) claimed it to have a strong mydriatic 
action in men. The pupil beg ins. to dilate in 20 to 50 minutes and mydri­
asis lasts twenty-four to thirty-six hours with the accomodation unim­
paired* A local application of a M/20 solution of the d-pseudo isomer 
dilates the pupil of albino rabbits* eyes (32) with preservation of the 
light reflex.
6* Action on smooth muscle* Hasama (25) rejjorted that in large doses 
propadrine can dilate the intact, but constricts perfused bronchi. Levy (78) 
stated that perfusion into the bronchi of doses of 0*5 to 0.1 mg. produced 
vasoconstriction, and did not modify the vasodilatation produced by epin­
ephrine. Alles and Prinzmetal (86) observed a slight bronchodilation in 
dogs and cats. Tainter et al (87,25) found only a bronchoconstrictor 
response in perfused guinea pig lungs and practically no dilator action on
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bronchial spasms produced by histamine in dogs# He therefore regarded 
it as giving negative bronchial effects.
In 1:75,000 concentrations it produces a lessening of the tonus 
and a diminution in amplitude and frequency of peristalsis of the isolated 
rabbit intestine (78)• The pregnant cat uterus in situ is contracted 
while the non-pregnant uterus is slightly relaxed (69) • It generally aug­
ments isolated rabbit and guinea pig uteri (32,88).
7. Toxicity. Its toxicity has been determined under various conditions. 
Chen, Wu, and Henricksen (32) state that propadrine has an M.L.D. of 75 mg./Kg 
for rabbits (intraven.) and is thus less toxic than ephedrine which has an 
M.L.D. of 60 mg./Kg. Other toxicity reports are summarized in the follow­
ing table;











Guinea pig 350,(20) 600 (4)
Rabbit 75-90
Dog over 500 (4)
8 . Effect on the blood sugar of rabbits. This study was carried out 
by Kr&niz and Hartung (89) on rabbits which had been starved twenty-four 
hours before administration of the drug. A maximum rise or fall of blood 
sugar occurred 30 to 70 minutes after intravenous injection. It was found
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that 20 to 30 mg ./Kg# influenced the blood sugar. However the results 
were variable and the influence was not marked, being either hypo or 
hyperglycemic# Nevertheless the following trends were noticed*
a* Thirty minutes after injection the tendency of activity was 
toward a mild hyperglycemia in most cases, approximately 60%  
resulting in a rise of about 1 0  mg#/l0 0  cc* of blood# 
b# Seventy minutes after injection the tendency of the blood sugar 
level was to fall below the fasting level, most of the deter­
minations indicating a fall of about 18 mg.
When administered subcutaneously, a dose of 100 mg./Kg. was without ap­
preciable effect on the blood sugar level, as was an oral dose of 200 mg./Kg# 
9* Potentiation of the pressor effect of epinephrine* Munch and 
Hartung (29) conducted experiments on dogs anesthetized with morphine and 
chloretone in order to determine the effect of a single dose of propadrine 
and related compounds upon the subsequent pressor effect of epinephrine#
It was found that propadrine and ephedrine in doses of 1 mg./Kg# in­
travenously potentiated or increased the subsequent epinephrine rise 2*75 
times# An increase in dosage of these drugs increased this potentiation 
effect. Phenylethanolamine and phenylbutanolamine produced no similar 
effect in the same dosage, and from this these investigators concluded that 
the ability to potentiate the pressor responses of epinephrine was char­
acteristic of the phenylpropanolamine compounds#
The results of oral administration were more variable than those 
obtained with intravenous injections. It appeared that potentiation was 
not produced by the doses employed (up to 75 mg.)# Those doses failing 
to show such an effect also failed to show any definite evidence of an 
increase in blood pressure. However, 100 mg./Kg. orally produced a definite 
increase in the blood pressure of dogs and the results suggested the
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possibility of potentiation. They concluded that the oral administration 
in the doses employed did not definitely produce potentiation. Ephed— 
rine produced similar results on oral administration. A clinical report 
by Csepar and Doleschall (90) reported that the administration of ephed­
rine caused a subsequent injection of epinephrine to produce a greatly 
potentiated increase in blood pressure.
This potentiation effect was also observed by Tainter (15) who 
observed in addition that arterenol was similarly sensitized by propadrine. 
Hence this alteration in functional response is not peculiar to epinephrine 
alone, but presumably involves the sympathetic receptors.
10. Bio-assay of propadrine. Githens (81) attempted to find a suit­
able method of assaying propadrine and ephedrine. Although their quali­
tative actions have been elucidated fairly well, none of these actions 
lend themselves to accurate quantitative analysis. Their actions differ 
so widely, quantitatively at least, from one animal to another, and all 
are so markedly influenced by slight experimental differences which 
are not readily analyzed, that it is difficult to obtain quantitative 
determinations by comparing the action on one animal directly with that on 
another. Most biologically assayed drugs acting on the autonomic system, 
such as epinephrine, are assayed by comparing the results obtained on a 
particular animal or tissue with those obtained on the same animal or 
tissue with a standard solution of the drug being tested. In the case 
of propadrine and ephedrine however, this method is impractical since their 
effects are altered or reduced by previous administrations (tachyphylaxis), 
so that whichever sample is first employed will appear to be the stronger. 
This reduced effect on repeated administrations is true not only of their 
pressor actions but also of their effects on isolated tissues. More­
over, there is no fixed relation between the rise caused by the first and
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by subsequent doses# This fact makes it impossible to standardize the 
test animal by giving a definite dose of a standard preparation and to base 
the assay on the relation between the rise caused by this and the rise 
following the administration of a solution of unknown strength. If the 
doses are much smaller than that giving a maximum response f this tachy- 
plaxis tends to become less with repetition of the dose, and eventually 
subsequent doses may give substantially identical effects, although the 
response is never as regular as it is with repeated injections of the same 
dose of epinephrine*
In the attempt to develop a method of biological assay which would 
give quantitative results within 10 to Z 0 % 9 Githens investigated four 
methods.
a. The mydriatic action on the isolated frogis eye. Although 
mydriasis was caused by all dilutions of propadrine down to 1 :8 , 0 0 0  
there was no relation between the strength of the solution and the 
degree of mydriasis. In some cases a weaker solution caused more 
dilatation than a stronger solution even when the comparison was 
made between the two eyes of the same frog.
b. Action on the isolated uterus of the guinea pig. There was a 
lessened response with repeated doses, the reduction being at the 
same time irregular. This method did not seem promising for quanti­
tative studies.
c. Pressor relation to epinephrine. Dogs anesthetized with chlore- 
tone were used. Each dog was standardized by determining its sensi­
tivity to epinephrine, and the pressor effect of a single dose of the 
drug was compared to the pressor effects of graded doses of the epin­
ephrine given previously. The strength of the drug could thus be ex­
pressed in terms of its relation to epinephrine. It was found that
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different dogs vary markedly in their response to propadrine and 
ephedrine. In a series of forty dogs no quantitative relationship 
was found between the dose and the effect* For example, the 1600 mg* 
dose caused a rise of only 50 nun* of mercury while another dog given 
only 590 mg*/Kg. showed a rise of 110 mm* The relation was no more 
exact when the rise was calculated in terms of per cent of the original 
blood pressure. This variation of responsiveness in individual animals 
was noted by other workers both with epinephrine and ephedrine* Using 
forty-two dogs in the test with propadrine the relation varied from 
1:125 to 1:1000, the average being 1:495* Moreover, the variation of 
the animals to epinephrine did not parallel that to propadrine.
d. Effect of repeated doses on the blood pressure. With this method 
originally devised by Feng and Read (94), it was possible to obtain 
results within 2 0  or even 1 0 % with only one or two dogs in each test. 
Anesthetized dogs were given repeated doses of ephedrine or propadrine 
intravenously at intervals of an hour. Each dose contained 1 mg. of 
a standard solution or an approximately equal amount of solution in 
each test. The dose was not adjusted to the weight of the dog as 
no relationship between this and the response to a fixed dose was 
found. The dog was given first 1 mg. of the standard and the rise 
measured* At the end of an hour, it was given the solution under 
test, and at the end of another hour, the standard was given once more 
in the same dose* This was continued at hourly intervals, preferably 
four doses of each being given* The averages of all the doses of 
each sample were then taken. If there was a discrepancy of more than 
2 0 % between them, it was fairly safely concluded that this represented 
a real difference in the potency of the solution. This method takes 
advantage of the same amount of tachyphylaxis induced by small doses
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of the drug given at long intervals* The following is an illustra­
tive example in which two 1 %  solutions (A and B) of the same lot of 
propadrine were assayed according to this method* In some cases the 
rise from the first injection was unduly large, and in such cases 
this rise was excluded in the calculation* The injections were made 
on the same animal*
Time Sample Dose-mg* Rise-mm*
10:55 A 1 2 2
11:55 B 1 1 2
13:00 B 1 1 2
14:00 A 1 10
15:00 A 2 14-
16:00 B 2 14
Average rise of injections of A —  13 mm.
Average rise of injections of B —  12 mm.
Since the result is within 1 0 %  the solutions are approx­
imately of the same activity*
11* Clinical studies* Several references to the clinical use of 
propadrine appear in the literature. Chen, Wu, and Henricksen (32) ad­
ministered it orally in 50 mg. doses to two individuals and found that it
produced a maximum rise of 16 mm. and 30 mm. of mercury in the systolic 
blood pressure. Stocfefcoâ  Pace, and Tainter (91) observed that topical 
application of a 5 % solution to the nasal mucosa of patients with acute or 
or chronic sinusitis produced constrictor effects equal to that of ephed­
rine and synephrine, and showed no evidence of local irritation, whereas 
ephedrine produced burning and irritation in 2 5 %  of the cases. Black (92)
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reported its use in the symptomatic control of hay fever and in asthma in 
a series of one hundred and thirty-one patients. He found that though 
it is only equally as effective as ephedrine it is relatively free from 
the side effects such as insomnia, nervousness, motor restlessness, and 
nausea commonly experienced following the administration of ephedrine«
This obviates the necessity of combining with it a sedative and makes it 
possible to use it at frequent regular intervals. Its use every three 
or four hours gave more relief to the patient suffering with urticaria 
and neurotic edema (angio) than any other medication that he has found.
Boyer (93) administered as much as 3/4 gr. of the hydrochloride every two 
hours for five days or more to a series of forty-four patients suffering 
from asthma, without any toxic manifestations. 19$ of the patients re­
ported it to be inferior to other forms of medication, 1 1 $ claimed it to 
be equally efficacious to previous medication, and 8 $ reported it to 
give the greatest symptomatic improvement. Clinically, bronchial spasm, 
rhinitis, and sneezing were relieved but in Boyer*s experience, its out­
standing value is the absence of side reactions encountered with the use 
of ephedrine. It may be safely used in cases of hypertrophy of the prostate 
gland where retention of the urine is produced by ephedrine. In children 
it does not produce restlessness, or walking or talking in their sleep. 
Tachycardia and palpitation were not observed as in the case with ephedrine. 
He therefore concludes that propadrine is a satisfactory and valuable 
therapeutic agent in the treatment of allergic manifestations.
II. Ring Substituted Propadrines
A number of ring substituted propadrines have been prepared and their 
physiological properties studied. The effect of introducing various
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substituents into the phenyl group of propadrine is summarized in table 7 *
p—Hydroxypropadrine is superior to the unsubstituted compound since 
it is more active and less toxic, while the m-hydroxy compound is still 
more active though also more toxic • The increase in pressor activity pro­
duced by a meta hydroxyl substituent is also demonstrated in the case of 
3-hydroxy*-> 4-methylpropadrine which is more active than 4 -methylpropadrine •
3,4-Dihydroxypropadrine, containing the two phenolic hydroxyls in the same 
positions in which they occur in epinephrine, is the most active member of 
this series (5 to IE times as active as propadrine) and the most toxic (about 
7 times as toxic as propadrine in rabbits). In anesthetized dogs it pro­
duces blood pressure tracings indistinguishable from that of epinephrine 
except as to dosage. Tainter (IE) states that the major part of its cir­
culatory action is of a true sympathicotropic nature. The introduction of 
an ortho hydroxyl decreases activity and increases toxicity. Thus o-hydroxy- 
propadrine is less active than propadrine while E,4-dihydroxypropadrine is 
inactive in small doses and depressor in large doses ( 8  mg.) With none of 
the active phenolic compounds was tachyphylaxis observed by Hartung and 
co-workers (30).
The introduction of a methyl group into the meta position of both 
propadrine and p-hydroxypropadrine makes the new compound decidedly more 
toxic and less active. A para methyl group exerts a similar effect.
As indicated in table 7, the other substitutions into the aromatic 
nucleus of the propadrine molecule, which have been investigated, pro­






4 / ^  CHOH.CIR’K^ .CH3 
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Substituents Toxicity rabbits Times weaker 
than 
epinephrine





cats min.(15)2 3 4
intraven,
M.L.D. mg./Kg.
H H H 75 (32) 
75 (33)
60 (15) 1 10
H H OH 130 (32) 
100-125 (30)
67 (15) 1,5 11
H OH H 16 (30) 11.5 (15) 3 8
OH H H 40 (30) 200 (15) Less than 1 7
H OH OH 11 (30) 4 (54) 
12 (12)
12 or more 1 (12)
OH H OH 12 (30) inactive (30)
8 mg,-depressor 
(12)
H H ch3 33 (33) 5 mg. gave only 18$ 
rise, larger doses- 
fall followed by use 
(15)
0.6 11
H ch3 H 30-35 (20) 168 (15) 0.20 (20) 22
H H OUe 35 (30) Fall of blood pres­
sure (15)
0.5 17
OMe H H 25 (30) 226 (15) 1 9
OMe H OMe 21 (30) greatest use 11/ 
dose grea,ter than 
10 mg.-depressor(15)
1 12
H ch3 OH 20 (30) 288 (15) 2 11
H OH CH3 90 (30) 151 (15) 2 12
H H c6h5 17.5 (30) trace of ac­tivity (20)
H H Cl 25 (10) 248 (15) 0.04 (20) 6
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review of the halogen ring substituted pressor m i n e s
3,4-Dichloro-w-aminoacetophenone hydrochloride (XVIIl) and its corres­
ponding alcohol (XIX) were found tty Glynn and Linnell (64) to possess pressor 
action, though much less than that of epinephrine* Compound (XVIII) is
ClCl
(XVIII) (XIX)
about l/500th and (XIX) l/SOOth to l/250th as active as epinephrine in 
spinal cats* They state that: wthe toxicity of °<-5,4-dichlorphenyl-^-
aminoethanol hydrochloride by intravenous injection into mice is about 
l/240th that of 1-epinephrine. Doses given orally (by stomach tube) in­
dicated that the compound is active when administered in this way, and it 
must be emphasized that the side chain does not contain a third carbon atom 
to which oral activity has been attributed *« The pressor activity of this 
compound was abolished by a previous injection of cocaine.
Edkins and Linnell (65) studied the effect on physiological pro­
perties of halogen substitution in W-aminoacetophenone andoc-aminopropio- 
phenone. Their results are summarized in table 8 . Compared with the un­
substituted compounds, both of the 5-Cl,4-0H compounds are considerably 
weaker* The position of the halogen in the phenyl nucleus seems to be an 
important factor* Thus the introduction of chlorine or bromine into the 
meta-position almost doubles pressor activity, while no difference is
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4 5 4 3
H 1 H 1 0 .350 H H 19 . 2 0 0
Cl Cl 9 OH Cl 3 .700
OH Cl 3 .500 Br H 6 .150
Ci H 8 .300 Cl H 7 .175
Br H 5 .175
H Cl 17 . 2 0 0
H Br 18 . 2 0 0
observed between the effects of chlorine and bromine* On the other hand, 
when the halogen occupies the para position, a decrease of activity, espe- 
cially marked in the°(-*aminopropiophenone series, is produced. The
3,4-dichloro compound has a similar activity to the unsubstituted amino 
ketone and hence the presence of the para halogen has counterbalanced the 
increase in activity due to the presence of the meta-substituent. Sim­
ilarly the para-hydroxyl more than negativates the increase of activity 
produced by a mete, halogen* Contrary to other series previously discussed, 
both X-aminopropiophenone hydrochloride and the alcohol derived from it 
were found to be more active than w-aminoacetophenone hydrochloride and its 
reduction product. This is an example of compounds with a 5 carbon side 
chain being more active than those with only 2  carbons in the side chain.
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A consideration of the toxicities of these compounds reveals little 
correlation between toxicity and constitution. Both 3—Cl,4—OH-derivatives 
are the least toxic of the substances considered# The 4-Br—derivative is 
more, and the 4—Cl-derivative is less toxic than the 3 —C1 -kJ-aminoacetophenone 
hydrochloride# 4-Br-0£-aminopropiophenone hydrochloride is the most toxic 
of the compounds studied, and with the exception of the meta-substituted 
amino-ketones, replacement of chlorine with bromine increases toxicity#
More generally a consideration of toxicities shows they are not in the same 
order as the pressor activities# All the halogen derivatives considered, 
except those containing a nuclear hydroxyl are more toxic than the parent 
compounds ,
Gurd (69) also studied the same compounds and substantiated the order 
of pressor activities reported by Edkins and Linnell# In addition they 
found that all exhibit some sympathomimetic properties on isolated organs, 
though in certain cases there was some evidence that while small doses 
produce sympathomimetic effects, larger doses produce opposite effects#
Tainter observed that 1-epinephrine is one hundred and eighty-three 
times as active as .0 -pherjy 1  ethylamine (15) and three hundred and sixty- 
eight times as active as p-chlor-P-phenylethylamine (7)# Thus the intro­
duction of chlorine into the para position ofr? -phenylethylamine decreases 
its pressor activity in cats by one half# Cocaine almost completely 
abolishes the pressor action of the chloro compound, and thus it may be 
classed as a pseudosympathicotropie drug#
The only studies of the effect on physiological properties of the 
introduction of fluorine into a pressor molecule found in the literature 
were those reported by Hansen (70) and Suter and Weston (71)# The former 
found that 3-F,4 -OH-U-aminoacetophenone (XX) as well as 3-Cl,4-0H-*UJ-amino- 
acetophenone possess vasopressor properties weaker than those of adrenalone (XXI)
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OH OH
CO *CH2 NHCH3  CO#CH2 MiCH3
(XX) (XXI)
in anesthetized dogs* Moreover the fluorine compound is slightly less 
active than the corresponding chlorine analog* Suter and Weston in study­
ing the effect of p-fluorine substitution I n J f i -phenylethylamine -phenyl- 
isopropylamine, and J^-phenylethylmethylamine found that in female white 
mice (orally) the fluorine compounds were more toxic than the unsubstituted 
parent molecules* In dogs p~fluoro-*p-phenylisopropylainine and-P-phenyl- 
isopropylamine showed similar pressor activity* Insufficient data were- 
given to compare the pressor activities of the two p-fluorine derivatives 
with their unsubstituted parents*
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OBJECT AMD METHOD OF INVESTIGATION
The available steadies of the halogen pressor amines, previously sum­
marized, afford some Indication of the effect of halogen substitution and 
position isomerism upon sympathomimetic activity. However it is important 
to note that these studies were made with incomplete series of compounds 
in which the various halogens were not present in the same parent molecule. 
These investigations were also limited by the lack of ortho halogen sub­
stituted members. Furthermore, except for p-chlorpropadrine, the compounds 
investigated were not amino alcohols, which have been shown to be the most 
active of the sympathomimetic amines. For these reasons it is difficult 
to draw definite conclusions and satisfactory correlations.
Therefore this investigation was undertaken with the object of making 
available for future pharmacologic study a series of halogen compounds in 
which various halogens have been introduced into different positions of the 
same pressor amine. Propadrine was selected as the parent In which to study 
halogen substitution since it contains the optimum structuresJ namely, the 
aromatic nucleus and primary amino group attached to adjacent carbon atoms, 
a three carbon side chain which confers oral activity, and an alcoholic 
hydroxyl on the carbon atom bearing the phenyl group.
In addition, as seen by referring to table 7, since the effects of 
a number of ring substitutions in the propadrine series have been well 
established, a further extension of this series by the inclusion of other 
halogen derivatives would make possible a more complete correlation of the 
effects of halogen substitution with those of the other substituents.
rb has been shown that propadrine and a number of its ring substituted 
derivatives may readily be obtained by a general method, involving nitro- 
sation of the corresponding ketones and subsequent catalytic reduction of 







Ar * CHOH • CHHH2. CH3
Since both stages of the synthesis give good yields, it was proposed to 
adopt this scheme in this investigation*
For the necessary intermediate halogen-substituted propiophenones the 
following series of reactions was planned*




(b) Ortho and meta halogen ketones (X—F,Cl, and Br) 
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All temperatures recorded in this investigation are Centigrade degrees 
and were determined with Anschutz w stem—immersion ** thermometers*
Analyses for nitrogen were carried out by the Kjeldahl-Gunning methodj 
analyses for Cl (as HC1) were carried out by the Volh&rd method*
Volumes of hydrogen recorded in the catalytic reductions are uncorrected* 
The semicarbazones of the ketones were prepared by an adaptation of 
the method of Shriner and Fuson (101) • One gram or 1 cc. of the ketone was 
added to a solution of lg* of semicarbazide hydrochloride and l*5 g* of 
sodium acetate in 5 cc* of water in a small flask. Sufficient alcohol was 
then added, except in the case of m-nitropropiophenone where dioxane was 
used fjust to dissolve the ketone. The solution was then heated to the boil­
ing point and allowed to stand in a cool place until the semicarbazone pre­
cipitated. The crystals were filtered off and recrystallized from dilute 
alcohol.
In experiments where compounds were oxidized to their corresponding 
benzoic acid derivatives in order to verify the position of the halogen in 
the ring, the oxidations were carried out according to the directions of 
Shriner and Fuson (102) using potassium permanganate*
Approximately lg. of compound was added to 80 cc. of water contain­
ing 4g. of . potassium permanganate* The mixture was heated under reflux 
for Z  hours, cooled, and carefully acidified with sulfuric acid. The 
excess manganese dioxide was removed by the addition of sodium bisulphite.
The precipitated acid was collected on a filter and dissolved with 10^
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sodium bicarbonate solution on the filter* The acid was reprecipitated 
by addition of concentrated hydrochloride acid and, unless otherwise 
Specified, was recrystallized from dilute alcohol*
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II* Synthesis of Ketones
A« Para Halogen Propiophenones 
The following methods are recorded in the literature for the pre­
paration of p—chloro— and p—bromopropiophenone*
(l) Friedel—Grafts Synthesis* Collet (95) prepared these two com­
pounds by the reaction:
X
CH3 CHgC0Cl + HC1 (X=Br or Cl)
AICI3 |[j
coch2 ch3
p-Chloropropiophenone was obtained as colorless crystals, melting at
o  o55-56 C. The p-bromo compound melted at 44-5 • No yields were reported
by this investigator«
Hartung, Munch and Crossley (20) obtained p-chloropropiophenone in 
a yield of 81$ by reacting propionyl chloride and chlorobenzene in the
Q
presence of aluminum chloride* They reported a boiling point of 115 (5mm*) 
for this compound*
Edkins and Linnell (65) also using the Friede1-Crafts reaction, pre­
pared these two compounds using the conditions described by Adams and 
Noller (96)* Propionic anhydride was gradually added to a hot solution of 
the appropiate aryl halide in carbon disulphide containing suspended
aluminum chloride* The p-chloropropiophenone was obtained as a liquid
0distilling at 152 (50 mm.) in a yield of 57% .  It solidified on strong
ocooling and on recrystallization from absolute alcohol at -15 , formed
o
fine white needles, m*p. 55.8 (corr.) p-Bromopropiophenone was obtained
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in a yield of 56.5$, b.p, 167 (30 mm,), Re crystallized by freezing from
me thoxy styrene in a sealed tube at 300 , Lauer and Spielman (97) were able 
to obtain p-chloropropiophenone in a 6 8 % yield according to the reaction:
C=CH2  C0CH2 CH3
OCHg
o o
Their product, boiled at 134-7 (31 mm.) and its semicarbazone melted at 175-6 •
Although the yield is satisfactory, the preparation of the intermediate 
styrene derivative requires four reactions.
In this investigation p-fluoro-, p-chloro-, and p-bromopropiophenone 
were prepared by two adaptations of the Friedel-Crafts reaction.
Procedure 1 consisted of a modification of the method used by Adams 
and Noller (96) for the preparation of p-chloroacetophenone and involved 
the following reaction:
In a 2-1. round bottomed, three-neck fla.sk, fitted with a mechanical 
stirrer, separatory funnel, and reflux condenser connected to a gas ab­
sorption trap for disposing of evolved hydrogen chloride gas, was placed 
1  mole of the aryl halide and 400 cc. of carbon disulphide which previously
alcoholic solution, this ketone occurred in fine white needles, m.p. 4 7  .





had been dried over anhydrous aluminum chloride • To "this mixture was "then 
added 147 g. (1.1 moles) of anhydrous aluminum chloride (E.K# Co). Then 
92*5 g. (1 mole) of propionyl chloride was added slowly to the well stirred 
mixture over a period of about 45 minutes# The addition of the acid chlo­
ride was accompanied by a vigorous evolution of hydrogen chloride, refluxing 
of the carbon disulphide, gradual solution of the suspended aluminum chloride, 
and the darkening of the reaction mixture from yellow to a dark red-brown. 
After addition of the acid chloride, gentle refluxing was maintained by a 
water bath until the evolution of hydrogen chloride had practically ceased 
(about three hours)#
A condenser was attached to one of the side necks and the carbon di­
sulphide distilled off (steam bath)» The reaction mixture was cooled to 
room temperature and the complex decomposed by the addition of an ice-water- 
hydrochloric acid mixture. Additional concentrated hydrochloric acid was 
added when necessary to dissolve any remaining aluminum compounds. The 
dark oil which separated was removed and the aqueous layer extracted with 
ether. The oil was dissolved in ether extracts which were then washed 
twice with water, with 1 0 %  sodium hydroxide solution until the washings 
were alkaline, and twice more with water. The ethereal solution was dried 
over calcium chloride, filtered, and the ether removed by distillation 
from a water bath. The residue was distilled from a Claisen flask. In the 
case of p-fluoropiophenone the desired fraction was redistilled while in 
the cases of p-chloro- and p-bromopropiophenone, the compounds were re- 
crystallized by the gradual addition of cold water to their alcoholic 
solutions. Physical constants and yields of the three para halogen pro- 
piophenones are recorded in table 9.
Procedure 2 consisted of a modification of the above procedure and 
was employed in an attempt to improve the yields previously obtained# This
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aim was accomplished since in all cases previous yields were improved*
The modifications introduced consisted primarily of the use of suction to 
remove more completely the evolved hydrogen chloride, and the decomposition 
of the product in the presence of solvent to decrease the violence of the 
decomposition and mechanical loss*
The aryl halide, pripionyl chloride, and aluminum chloride were re­
acted in carbon disulphide as the solvent in the same proportions, manner, 
and apparatus described in the preceding procedure* After all the acid 
chloride had been added, gentle refluxing was maintained on a water bath 
for about two and one-half hours, at the end of which time the evolution of 
hydrogen chloride had greatly lessened* The gas absorption trap was re­
moved, the end of the reflux condenser attached to a water pump, and suction 
applied for an additional hour to remove hydrogen chloride more completely. 
The suction was adjusted to prevent too vigorous refluxing of the solvent*
At this stage the reaction mixture had acquired a dark red brown color*
The reaction flask was surrounded by a cold water bath, and the complex 
decomposed in the presence of the solvent hy the dropwise addition of water 
from the separatory funnel. Too violent refluxing of the solvent was 
prevented by regulating the rate of addition of the water, and stirring 
was continued during the decomposition. When the vigorous evolution of 
hydrogen chloride had ceased, the decomposition was complete and any sus­
pended aluminum compounds were dissolved by the addition of hydrochloric 
acid. In order to allow a better separation of the carbon disulphide and 
aqueous layers, which had become partially emulsified, the reaction mixture 
was filtered with suction*
After removing the carbon disulphide layer, the aqueous solution was 
extracted twice with carbon disulphide. The carbon disulphide solutions 
were combined, washed twice with water, with 10# sodium carbonate solution
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until the washings were alkaline, twice more with water, and dried over 
calcium chloride. The solution was filtered and the carbon disulphide 
removed by distillation from a water bath through a short column* The 
lower boiling fractions were removed by distilling the oily residue at at­
mospheric pressure, and the desired ketones were distilled at reduced pres­
sures from a Claisen flask*
The yields obtained by this procedure and the melting points of the 
semicarbazones prepared are also recorded in table 9*
All the ketones by permanganate oxidation produced their correspond­
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B. Meta Halogen Propiophenones
Propiophenone
This intermediate was prepared by the Friedel-Crafts reaction. In 
a typical m m  185g. (E moles) of propionyl chloride was reacted with 8O0cc, 
of benzene (the excess benzene serving as the solvent) containing E93 g.
(E.E moles) of anhydrous aluminum chloride according to procedure 2  pre­
viously described for the para halogen propiophe nones. Distillation of
the crude product gave E45g. (yield of 91%) of propiophe none (yellow oil),
0 o
b.p. 75-8 (Emm.), S16-19 (atm.).
m-Nitropropiophenone -Nitration of propiophenone.
m-Nitropropiophenone had been previously prepared by the nitration of
propiophenone•
Hartung and co-workers (30) obtained this compound in yields of E7-50%, 
o
m.p. 97 (from 70% alcohol), by adding propiophenone slowly to cold agitated
ofuming nitric acid below 10 (75 cc. acid/0.1 mole ketone). An oily by­
product which they stated to be undoubtly the ortho isomer was also obtained.
o
Barry (99) reported a melting point of 100 after recrystallization
from alcohol for this compound which he obtained by dropping propiophenone
on red fuming nitric acid. A syrupy product, probably the ortho isomer,
was obtained when warm fuming nitric acid was used,
Elson, Gibson and Johnson (100) ran propiophenone in lots of 30 cc.
ointo 140 cc. of stirred nitric acid (d. 1.5) kept below 0 . After 1/S 
hour the product was poured on ice and the crystalline meta compound was
oseparated and recrystallized from alcohol, m.p. 98-100 . From the filtrate, 
made alkaline and extracted with ether, was obtained o-nitropropiophenone 
after evaporation of the ether. No yields were reported for this nitration.
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In this investigation, preliminary experiments were tried using various 
nitrating mixtures, such as sulfuric and cone* nitric acids, sulfuric and 
fuming nitric acids and glacial acetic and fuming nitric acids* However, 
it was found that the use of fuming nitric acid alone gave the best re­
sults* Thus it was decided to use fuming nitric acid (Bakeris C*P* grade-d 1*5) 
for the subsequent preparation of m-nitropropiophenone, as well as the
o-isomer* In the first series of experiments with this reagent the re-
oaction temperature was kept below 0 by the addition of solid carbon dioxide
chips to the reaction mixture* At these temperatures little or no oxidation
products were produced*
In a typical run, 300 cc* of fuming nitric acid was placed in a liter
beaker surrounded by an ice-salt-water bath equipped with a mechanical
ostirrer, dropping funnel, and thermometer. The acid was cooled to -10 by
the addition of chips of solid carbon dioxide and 53*6 g, (0*4 moles) of
propiophenone was slowly added from the dropping funnel with stirring.
o oThroughout the addition, the temperature was kept between -10 and -5 
by the further addition of solid carbon dioxide as required and by re­
gulating the rate of dropping of the propiophenone*
Stirring was continued for 10 minutes after all of the propiophenone 
was added, and then the reaction mixture was poured over crushed ice. The 
yellow oily crystals of m-nitropropiophenone which separated were removed 
by filtration with suction and washed successively with water, 10% sodium 
carbonate, and again with water on the filter* The crystals were washed 
finally with a little cold 90% alcohol to remove adhering o-nitropropiophenone*
The crude meta isomer was then re crystallized from 95% alcohol. 43g. of
oslightly yellow crystals melting at 98.5-99 was obtained, a yield of 60%.
oSemicarbazone - m.p* 188-9 •
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The aqueous filtrate and washings were extracted with ether to re­
move the o—nitropropiophenone which was present as a tan oil, the ether 
extract dried over calcium chloride and filtered# The ether was removed 
by distillation from a hot water lath and the crude o—nitropropiophenone 
(dark oil), together with that obtained by removal of the alcohol from the 
alcoholic wash, weighed 24 g. (30$ yield),
The negligible precipitate produced by acidification of the sodium 
carbonate wash indicated that the nitration was accompanied by practically 
no oxidation,
A second series of nitration experiments was undertaken with the object 
of studying the effect of higher temperatures on the course of nitration, 
and to obtain if possible higher yields of the ortho isomer which was re­
quired as an intermediate in the preparation of the ortho halogen pro­
piophe nones. At each temperature studied, two half-mole portions of 
propiophenone were nitrated in two separate runs and the combined re­
action products, representing 1 mole, were isolated and purified together. 
This procedure of nitrating each mole of propiophenone in two separate 
runs was adopted since previous experience had shown that temperature con­
trol for quantities larger than 0.5 moles was more difficult than for 
smaller amounts. In addition, when larger quantities are used, the initial 
portions of propiophenone are required to remain in contact with the nitric 
acid for longer periods, thereby increasing the tendency for oxidation to 
take place. The following general procedure was adopted for this nitration 
study and includes a more efficient method than that previously used for 
the isolation of the products.
In a three-neck liter flask fitted with a mechanical stirrer, dropping 
funnel, thermometer and ice bath was placed 425 cc* of fuming nitric acid.
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Stirring was started and when the temperature of the acid had dropped to
the desired temperature, 67 g. (0*5 moles) of propiophenone was added from
the dropping funnel* The temperature of the reaction was maintained within 
o
+2 by adjusting the rate of addition and of external cooling* Stirring 
was continued for 5 to 10 minutes longer after the complete addition of the 
propiophenone•
The reaction mixture of two such runs was poured upon 2  1* of ice and 
water, and the yellow oily crystals which separated was filtered with suction* 
The aqueous filtrate was extracted with three 200 cc* portions of benzene, 
the benzene extracts combined, warmed to 60 and used to dissolve the pro­
duct on the filter. The benzene solution after washing three times with 
100 cc. portions of water, with 10% sodium hydroxide until the washings 
were practically colorless, and finally three times more with 100 cc. 
portions of water, was dried over calcium chloride and filtered. After re­
moval of the benzene by distillation through a short column, a mixture of 
the ortho and meta isomers was obtained. The oily o-nitropropiophenone was 
removed by washing the mixture on a filter with cold 95% alcohol in which 
the meta isomer is insoluble*
The ortho isomer was obtained as a brown oil after removal of the al­
cohol by distillation, and was placed in a refrigerator for several days 
to allow the separation of a small amount of the crystalline meta isomer 
which had been dissolved by it. The meta compound was filtered off, com­
bined with the other portion, and the total m-nitropropiophenone recrystal-
olized from 95% alcohol, m.p. 98.5-99 •
The sodium hydroxide washings were made acid with conc. hydrochloric 
acid and the ppt. obtained was washed thoroughly with water, dried over 
calcium chloride and weighed. This product was soluble in sodium bi­
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carbonate solution and was probably a mixture of ortho and meta nitro— 
benzoic acids.
Table 10 gives the yields of the products produced at the ■various 
temperatures of the nitrations.
TABLE 10








o-nitroprop i ophe no ne
Crude NaOH 
extractive
S • % g* % g.
10 92 51.4 67 37.4 4
15 85 47.5 66 36.8 7
20 74 41.3 63 35.2 9
25 64 55.8 61 34.0 16
m-Aminopr opi ophe no ne
The first preparation of this compound, as its hydrochloride, was
reported by Comanducci and Pescitelli (103) who obtained it by the reduction
oof m-nitropropiophenone with tin and hydrochloric acid at 60 • However
otheir reported melting point of 170 (dec.) for the salt is much lower than
reported by subsequent investigators.
Elson, Gibson, and Johnson (100) obtained the free amine by the reduction
of m-nitropropiophenone with iron and acetic acid. It was isolated in yields
°which were variable and as high as o 0 % 9 as a pale yellow oil, b.p. 168-9
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(15 mm,) which formed a yellow solid m.p, 42 «
Hartung, Miller, Munch, and Crossley (30) reduced m—nitropropiophenone
with tin and hydrochloric acid and obtained the free amine in yields of
i o65-69%* it distilled at 115— 2 0  (5-7 mm.) and its hydrochloride melted at
202.5*.
Since a number of reports in the literature have shovm that the aromatic 
nitro group can be converted to the primary amine in excellent yields by 
catalytic hydrogenation (104,105,106,107), this method came under con­
sideration as a possible means of improving the yields of m-aminopropio- 
phenone previously reported. Using a palladium on charcoal catalyst with 
benzene as the solvent it was found possible to reduce selectively the nitro- 
group of m-nitropropiophenone to the amine without affecting the ketone 
group. The use of benzene as the solvent facilitated the isolation of the 
amine as the hydrochloride from the reaction mixture in a relatively pure 
state, and may be a factor in preventing the undesired reduction of the 
ketone group, though this latter possibility was not sufficiently studied. 
Reductions were carried out both under ordinary pressures and under initial 
pressures of 500 pounds. The reaction involved is:
NO
pd-charcoal
(1 ) preparation of the catalyst. The palladium-charcoal catalyst was 
prepared by essentially the same method described by Hartung (60,106). A 
suspension of 1 g. of palladium chloride crystals or 10 cc. of a solution 
of palladium chloride (each cc. representing 0.1 g. of palladium chloride) 
and 10 g. of Norite (E.K. and Co.) in 200 cc. of distilled water was shaken
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in an atmosphere of hydrogen until saturated# The catalyst thus obtained 
was filtered off, washed thoroughly with distilled water, alcohol, and 
ether, and was kept in a vacuum desiccator over sulphuric acid until used#
-dOJlydpogenat ions < Three grams of catalyst was added to a solution 
of 53*7 g# (0#5 moles) of m-nitropropiophenone in 300 cc. of benzene# The 
mixture was shaken in an atmosphere of hydrogen in an apparatus similar 
to that described by Hartung (108)—  at room temperature and at approxi­
mately atmospheric pressure# The theoretical amount of hydrogen required 
to reduce the nitro-group to the arnino-group was absorbed in approximately 
13 hours, after which time the absorption of hydrogen ceased#
The reaction mixture was filtered to remove the catalyst, the filtrate 
placed in a separatory funnel, and the water formed during the reduction 
was drawn off from the benzene layer. The benzene solution was dried over 
anhydrous sodium sulphate and filtered# Diy hydrogen chloride gas was 
passed into the dried benzene solution until no more m-aminopropiophenone 
hydrochloride was precipitated# The precipitate was collected on a filter, 
using suction, washed with benzene, then with acetone until the precipitate
was colorless, and finally once with ether# m-Aminopropiophenone hydro-
ochloride was thus obtained in yields of 83-88%, m.p# 198-99.5 (dec#)# The 
brown discoloration which the compound often developed on standing in a 
vacuum desiccator could be removed by recrystallization from a mixture of 
ethanol and isopropanol (3:1) and charcoal# A larger yield of recrystallized 
compound was obtained by adding ether to the filtrate#
When the reductions were carried out under initial pressures of 
300 lbs#, the reduction was complete in approximately two and one-half to 
three hours. Thus the use of these elevated pressures increased the speed 
of the reduction about 4 times. In these experiments a pressure hydro- 
genator bomb (American Instrument Go#) fitted with a glass liner was employed.
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The reaction mixture was agitated by a mechanical rocking device, and the 
hydrogen absorption was followed by observing the fall of pressure on the 
attached gauge•
It was found possible to use the same catalyst for at least two runs, 
but its use a third time was not attempted because of the decreased activity 
of the catalyst during the second run* A reduction using a catalyst pre­
viously used once required twice as much time to absorb the theoretical 
amount of hydrogen as a fresh catalyst*
(5.) Ox line of m-aminopropiophenone* The formation of an oxime by the 
reduction product verified the presence of the ketone group. The solubility 
of this oxime in both aqueous acid and base is to be expected of a compound 
containing both an amino- and oximino group* The following preparation 
was used.
Two grams of hydroxylamine hydrochloride and 2  g. of m-aminopropiophenone 
hydrochloride were dissolved in 15 cc. of a saturated solution of sodium bi­
carbonate. The free amine which separated as an oil was just dissolved by 
the addition of alcohol* More bicarbonate solution was added in small portions, 
as well as sufficient alcohol just to keep the amine in solution, until the 
solution became slightly basic. At this point the oljime precipitated, and 
was collected on a filter and washed thoroughly with water. After recrystal­
lization from 50%  alcohol (charcoal) the oxime was obtained in long color-
oless needles, m.p* 112-113 .
(4) m-fn-Toluenesulphonamido) -propiophenone. Two grams of m-amino­
propiophenone hydrochloride and 2  g. of p-toluenesulphyonyl chloride were 
shaken with 15 cc. of 1 0 %  NaOH until all of the amine went into solution.
The solution was filtered, made acid, and. the precipitate which formed was
collected on a filter and recrystallized several times from dilute alcohol
0  ,(charcoal). Colorless needles m.p. 102-3 were obtained. Reported m.p.
97°-from alcohol (100).
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m-ffluor opr opi ophe none
A previous report of this compound m s  not found in the literature. 
However fluorine can generally be introduced into the aromatic nucleus by 
replacement of an amino group through diazotization and subsequent decom­
position reactions. This general scheme can be carried out in several ways.
(1) Decomposition of a diazopiperidide in the presence of concentrated 
hydrofluoric acid (109,110).
ArN=N-NCsH10 > ArF+N3+CsH10MH.HF
However the reaction is violent and cannot be conveniently used with 
quantities greater than 10-15 g. of piperidide.
(2) Decomposition of a diazonium chloride in the presence of conc. hydro­
fluoric acid (111).
(3) Diazotization of the aromatic amine and warming of the resulting 
diazonium compound in the presence of excess hydrofluoric acid (112).
(4) Heat decomposition of a diazonium borof luoride (113,114) •
ArN3EF4   ---* ArF+N3+BF3
The first diazonium borofluorides were prepared by Wilke-Dorfurt 
and Balz (115,116) who found them to be stable, insoluble salts,
Balz and Schiemann (115) found that these compounds could be de­
composed quietly and smoothly by heat with the production of the 
aromatic fluorine compound. This method has several advantages 
over the others. It has a widespread applicability, produces good 
yields, requires no special apparatus, and the intermediate boro­
fluorides are stable and can be easily prepared and isolated.
Because of its advantages as a laboratory procedure, the diazonium 
borof luoride method was used in this work to prepare m-fluoropropiophenone.
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The intermediate diazonium borofluoride was prepared by a method similar to 
that proposed by Balz and Schiemann (113), according to the reactions:
NaNO. HBF,
HC1
A solution of 83.5g. (0.45 moles) of m-aminopropiophenone hydrochloride
in 45 cc. of hydrochloric acid (d 1.19) and 200 cc. of water was placed in
a 500 cc. beaker surrounded by an ice-salt-water bath, and fitted with a
mechanical stirrer, thermometer, and dropping funnel. The solution was 
ocooled to 0-5 and some of the salt crystallized from the solution; however
as diazotization proceeded, the salt gradually redissolved. While stirring
vigorously, a solution of 34.5 g. (0.5 moles) of sodium nitrite in 60 cc. of
water was added slowly from the dropping funnel, keeping the temperature
oof the mixture at 0-5 • When the diazotization was complete, a cold filtered 
solution of 120 cc. of 48% borofluoric acid was rapidly added to the dia­
zonium solution and stirring was continued for 15 min. longer* The solid 
which separated was collected on a filter, using suction, and washed twice 
with cold alcohol, thoroughly with ether, and partially dried by drawing 
air through it. The resulting pinkish solid was dried overnight in a vacuum
desiccator over conc. sulphuric acid. The diazonium borofluoride was thus
oobtained in a yield of 98 g. (88%) and decomposed at 97-8 .
Initial experiments carried out for the thermal decomposition of the 
dry diazonium borofluoride by an adaptation of the method described by Flood 
(117) proved unsatisfactory in that a large amount of tar was formed and the 
yields of m-fluoropropiophenone were very small. However it was subsequently 
found that satisfactory yields of m-fluoropropiophenone could be obtained
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if the decomposition was carried out in the presence of an inert hydro­
carbon solvent# Toluene was selected as the solvent since its boiling point 
is somewhat higher than the decomposition point of the borofluoride# The 
decomposition proceeded according to the reaction;
The procedure used is as follows;
Toluene (550 cc#) was heated to its boiling point in a liter 3 neck 
flask fitted with a mechanical stirrer and a reflux condenser connected to 
a gas absorption trap for the evolved boron trifluoride# The stirrer was 
set in motion and 98 g# (#395 moles) of the diazonium borofluoride was 
added in 1 to 2  g. portions through one of the necks to the toluene kept 
just below its boiling point; each portion was added after the preceeding 
one had been decomposed. Toward the end of the decomposition some tar which 
had formed separated from the toluene solution#
After the decomposition was complete, the toluene solution was cooled 
to room temperature and washed three times with water, three times with 5 %  
sodium hydroxide solution, and finally twice with water# After drying over 
calcium chloride, the solution was filtered and the toluene removed by distil­
lation through a short column. The residue was fractionated under reduced
pressure and the m—fluoropropiophenone was obtained in a yield of 40 g# (67 #8̂ )
o
as a slightly yellow oil, b#p# 94-96 (4-5 mm,) which formed colorless crystals
o
when cooled in an ice bath. Its semicarbazone melted at 187.5-188 # Oxi­
dation with permanganate produced m-fluorobenzoic acid.
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m-Chlorooroniophenone
This compound was not. found described in the literature. It was pre­
pared by the Sandmeyer reaction by a procedure patterned after that described 
by Marvel and McElvain (118).
The cuprous chloride—  hydrochloric acid solution required for the re­
action was prepared by adding, with stirring a solution of 53*3 g.(0.175moles) 
of sodium meta sulphite and 40 g. (1 mole) of sodium hydroxide in 300 cc* of 
water to a warm solution of 162.3 g. (0*65 moles) of crystallized copper 
sulphate and 76 g# (1*3 moles) of sodium chloride in 500 cc* of water over a 
period of five to ten minutes* The mixture was allowed to cool to room tem­
perature and the cuprous chloride, which separated as a white powder, was 
washed thoroughly l̂y decantation and dissolved in a mixture of 200 cc* of 
hydrochloric acid (d 1.19) and 150 cc* of water.
Immediately following the preparation of the above solution, 92.7 g*
(0*5 moles) of m-aminopropiophenone hydrochloride in 300 cc* of water and 
200 cc* of hydrochloric acid (d 1*19) was diazotized in a liter beaker by 
the addition of a solution of 34.5 g. (0.5 moles) of sodium nitrite in 75 cc.
of water. The temperature of the mixture was kept at 0-5 throughout th© re­
action by an ice-salt-water bath. The cold diazonium solution was then 
poured rapidly into the stirred cuprous chloride-hydrochloric acid solution, 
and the resulting mixture became thick due to the separation of a solid com­
plex. The cold mixture was then allowed to warm up to room temperature, during
which time the complex began to break down with the evolution of nitrogen.




continued, and maintaining the temperature until the evolution of nitrogen 
ceased (1/2 — 1 hr.)# The orange crystalline solid which separated on cool­
ing the mixture was filtered off and dissolved in 200 cc# of benzene which 
had been previously used to extract the filtrate* The benzene solution was 
washed with water, with 5 %  sodium hydroxide solution, and again with water#
The benzene was removed by distillation and the residue distilled with steam* 
The distillate containing the yellow, solid m-chloropropiophenone was extracted 
with benzene, and the benzene solution washed with water, dried over calcium 
chloride, and filtered# The yellow solid, obtained after distilling off the 
benzene, was dissolved in 200 cc* of 95^ alcohol and the alcoholic solution 
was decolorized with charcoal* Water (75 - 100 cc*) was added to the filtered 
alcoholic solution which was then placed in a refrigerator over night to
complete the crystallization of the m-chloropropiophenone# A yield of 61 g#
o(72#4^) of colorless crystals, nwp* 45-46 was thus obtained# Semicarbazone, 
onwp. 179.5-180 • Permanganate oxidation of this ketone produced m-chloro- 
benzoic acid#
m-Bromopropiophenone
This ketone has been described by Elson, Gibson, and Johnson (100)*
They obtained it from m-aminopropiophenone by a Sandmeyer reaction as a
opale yellow solid, m.p# 36 , in a yield of 52^*
In this work it was also prepared by the Sandmeyer reaction from 




The cuprous bromide—hydrobromic acid solution used in the res.ction was
prepared from 33.5 g. (0.175 moles) sodium meta sulphite, 40 g# (1 mole) of
sodium hydroxide, 162.3 g. (0.65 moles) of crystallized copper sulphate,
and 72 g. (0*7 moles) of sodium bromide by the method described for cuprous
chloride* The cuprous bromide, obtained as a white powder, was washed
thoroughly with distilled water by decantation and dissolved in 200 cc. of
hydrobromic acid (48$) and 100 cc. of water.
Then 0.5 moles of m—aminopropioiDhenone hydrochloride was neutralized
with 20$ sodium hydroxide solution, the free amine separated, washed with
water, and dissolved in 84 cc. of conc. sulphuric acid and 350 cc. of water.
After diazotizing with a solution of 0.5 moles of sodium nitrite in 75 cc.
o
of water, keeping the temperature at 0-*5 , the diazonium solution was 
added to the cuprous bromide solution, the complex decomposed, and the 
m-bromopropiophenone isolated and purified as described for the m-chloro-
compound. m-Bromopropiophenone m s  obtained as colorless crystals, m.p.
O  o
37*5-40 in a yield of 47 g. (44$)* Semiearbazone m.p. 182 reported m*p.
o
180 (100). Permanganate oxidation of the ketone produced rn-bromobenzoic acid.
C. Ortho Halogen Propiophenones
o-Nitropropiophe none
This compound was erroneously reported by Comanducci and Pescitelli
€> ,(103) as a crystalline compound, m.p. 85 , obtained by adding propiophenone
Qto 136$ nitric acid at 40 . However, subsequent workers have shown that 
the compound is an oil. Moreover, during the present investigation the 
results of Hartung and Gibson (unpublished) were confirmed; namely, that 
if the reaction between propiophenone and nitric acid (d 1.5) is allowed 
to take place above 25-35°, the reaction becomes extremely vigorous and
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uncontrollable, brown fumes are evolved and only m-nitrobenzoic is isolated# 
Additionally, Comanducci and Pescitelli give no proof for the structure of 
their compound#
Hartung and co—workers (30), and Elson, Gibson, and Johnson (100) ob­
tained it as a side product in the nitration of propiophenone# The former
odescribed it as an oil, b.p# 153-60 (7-10 mm.)
Wohnlich (119) and later Auwers and Duesberg (ISO) prepared this ke­
tone according to the following reactions:
+CH3-C0-(j!-C00Et
0-01 C0-C-C00Etll /  \o ch3 co-ch3
C00H
C0CH2CH3
Wohnlich described the compound as a yel3.ow, thick oil with an a.romatic odor
b.p# 175 (25 mm#)—  yield 42-46%. The latter two investigators obtained it
in a yield of 40% as a yellow, thick oil which darkened in the air, b.p#
o  o
166—7 (15mm.), 161 (10—11 mm#)#
In this work, o-nitropropiophenone was prepared, along with m-nitro-
propiophenone, by the nitration of propiophenone with fuming nitric acid
as described above# The crude ketone after fractionating under reduced
o
pressure was obtained as a yellow oil, b.p. 152-5 (2-5 mm.) which darkened
on standing. From 69 g# of crude compound was obtained 54 g. of distilled
o  o




Comanducci and Pescitelli (105) reduced their purported o-nitro- 
propiophenone with tin and hydrochloric acid and obtained an amine of which 
the hydrochloride decomposed without melting at about 200 * However, since 
they obviously did not have o—nitropropiophenone, they could not have had 
o-aminopropiophenone •
Wohnlich (119) by the reduction of o-nitropropiophenone with tin and
cone* hydrochloric acid obtained the free amine as yellowish leaflets, m.p, 
o45-6 after recrystallization from petroleum ether,
Auwers and Duesberg (120) reduced o-nitropropiophenone with stannous 
chloride and conc. hydrochloric acid and obtained the free amine as light
o
yellow leaflets, m.p. 46-7 in a yield of 70% *
Elson, Gibson, and Johnson (100) reduced the crude o-nitropropiophenone, 
which they obtained from the nitration of propiophenone, with tin and hydro­
chloric acid. The resulting amine was isolated by steam distillation and
ocrystallized from the distillate in pale yellow plates, m.p, 46 .
In this work, o-aminopropiophenone was prepared by the catalytic hydro­
genation of o-nitropropiophenone, as described under m-aminopropiophenone, 
in benzene and using a palladium— charcoal catalyst.
To a solution of 53.7 g. (o,3 moles) of o-nitropropiophenone in lOOcc. 
of benzene was added 5 g, of the catalyst, already described, and the 
mixture hydrogenated in the bomb hydrogenator at an initial pressure of 
300 pounds. Before shaking was started, medium heat was applied for ten 
minutes. The theoretical quantity of hydrogen was absorbed in approximately 
seven hours after which time absorption ceased. The reaction mixture was 
filtered to remove the catalyst, the water formed in the reduction removed, 
and 300 cc. of benzene added to the filtrate which was then dried over 
anhydrous sodium sulphate. The amine was isolated as the hydrochloride
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salt- by t-he procedure described for m-aminopropiophenone hydrochloride •
o-Aminopropiophenone hydrochloride was thus obtained as a pink solid m.p. 
o
184-6 (dec*) in a yield of 75-79%* The salt darkened on standing*
It m s  found that a higher melting product could be obtained by the
following recrystallization. Ten grams of the amine hydrochloride was
dissolved in a boiling mixture of 125 cc. of isopropyl alcohol and 60 cc.
of ethanol and decolorized with charcoal. After cooling in the refrigerator,
6 g» of slightly tan crystals were obtained which began to darken at about
o175 and melted with decomposition at 187-88 • By the addition of ether 
to the mother liquor 5 g* more of the salt was obtained. However, for the 
purpose of this investigation, this recrystallization was not necessary*
The following derivatives were also prepared and re crystallized from 
dilute alcohol.






Borsche and Wagner-Roernmich (121) prepared this ketone by a Grignard
reaction.
COCHqCH




•̂ The oxime was prepared by the method described for tne oxime of 
m-aminopropiophenone ; it was sol* in aqueous acid and base.
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Their product was obtained in a yield of 70?o as a colorless oil which did 
not solidify, b.p. 95-9°(19 mm,)*
In this work o—f luoropropiophenone was prepared by decomposition of 
the diazonium borofluoride, prepared from o-aminopropiophenone hydrochloride, 
in the presence of a hydrocarbon solvent according to the reaction.
NaNO HBF,
HC1
o-Aminopropiophenone hydrochloride (0.3 moles) in 25 cc. of hydro-
ochloric acid (d 1.19) and 100 cc. of water was diazotized at 0-5 by the ad­
dition of a solution of 0.5 moles of sodium nitrite in 50 cc. of water.
To the cold diazonium solution was then added 70 cc. of borofluoric acid 
(42%) with stirring. No precipitate formed immediately as in the case of 
the meta compound, but after standing in the ice bath for 5-10 minutes, 
the diazonium borofluoride precipitated as a tan powder. After filtering 
off this salt with suction, a second batch of the diazonium salt was obtained 
b y  saturating the filtrate with sodium borof luoride. The total yield of 
diazonium borofluoride was washed on the filter once with isopropyl alcohol 
and then thoroughly with ether. After drying in a vacuum desiccator over




The diazonium borof luoride (59 g,) was decomposed by dropping "the dry
powder into 350 cc, of heptane, kept just below its boiling point as de­
scribed for the decomposition of the diazonium borofluoride prepared from 
m-aminopropiophenone. The crude o—fluoropropiophenone was fractionated under 
reduced pressure, and the fraction distilling at 12-13 mm, collected 
o—Fluoropropiophenone was thus obtained as a yellow oil which did not solidify
on cooling, b,p, 87-91 (12-B mm,), in a yield of 17 g. (47̂ ), Semicar- 
bazone, m,p, 143-4 • Permanganate oxidation produced o-fluorobenzoic acid,
o—Chloropropiophenone
A description of this compound was not found in the literature. It 
was prepared by the Sandmeyer reaction using the procedure described for 
m-chloropropiophenone•
A solution of 55,6 g, (0,5 moles) of o-aminopropiophenone hydrochloride
in 200 cc, of water and 125 cc, of cone, hydrochloric acid \?as diazotized 
0at 0-5 by the addition of 0,3 moles of sodium nitrite in 50 cc, of water.
This cold diazonium solution was added to a cold solution of 0,4 moles
cuprous chloride (prepared by the method already described) in 140 cc, of
cone, hydrochloric acid and 100 cc, of water. The mixture was allowed to
ostand for 15 minutes and heated at 70 with stirring for about one hour. The 
mixture containing the o-chloropropiophenone (dark oil) was extracted with 
benzene, the benzene extracts washed twice with water, twice with 5 %  sodium 




filtered. After removal of the benzene by distillation, the residue was
distilled under reduced pressure and the fraction distilling at 104-9
(12 mm,) collected# On redistillation, o-chloropropiophenone was obtained
oas a yellow oil which did not solidify on cooling, b.p. 105-6 (12 mm*) in 
a yield of 45 g. (85%), Semicarbazone, m.p# 172-3 • Permanganate oxication 
produced o-chlorobenzoic acid.
o—Bromopropiophe none
Elson, Gibson, and Johnson (100) prepared this ketone by a Sandmeyer
oreaction. They obtained it as a pale yellow liquid, b#p. 125 (12 mm.),
which did not solidify above -16°, in a yield of 75$.
Borsche and Scriba (122) obtained a 90% yield of this ketone by the
Grignard reaction using o-bromobenzonitrile and ethyl magnesium bromide*
o
Their product was a yellowish oil, b#p* 135-40 (16 mm#).
In this investigation, o-bromopropiophenone was prepared by the Sand- 




o-Aminopropiophenone hydrochloride (0.3 moles-55.6 g.) was neutralized 
with 20% sodium hydroxide and the free amine separated and washed with water. 
A solution of the amine in 50 cc. of conc. sulphuric acid and 200 cc. of 
water was diazotized at 0-5° by the addition of a solution of 0.3 moles of 
sodium nitrite in 50 cc. of water. The cold diazonium solution was added 
to a cold solution of 0.4 moles of cuprous bromide (prepared by the method 
described under m—bromopropiophenone) in 175 cc. of 48p hydrobromic acid.
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The mixture, containing the brown gummy complex, was allowed to stand 15
Ominutes and heated at 60—70 for about one hour# The o-bromopr opiophe none was 
extracted from the mixture with benzene, the benzene extracts washed twice 
with water, twice with 6 %  sodium hydroxide, again twice with water, dried 
over calcium chloride, and filtered* After removal of the benzene by dis­
tillation, the residue m s  distilled under reduced pressure and the fraction
Odistilling at 116-20 (10-11 mm.) collected. In redistillation, o-bromo-
propiophenone was obtained as a pale yellow oil which did not solidify on
ocooling, b*p. 116-18 (10—11 mm.) in a yield of 49 g. ( 7 6 . 6 % ) » Semicarbazone,
o om.p. 178-9 % reported m.p. 182 (100) * Permanganate oxidation produced
o-bromobenzoic acid.
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III, Nitrosation of the Ketones
The general nitrosation reaction applied to ketones of the type, 
Ar.C0.CH2R, where R is a methyl or an alkyl group, producing oximinoketones 
according to the equation
RONOAr.CO.CHgR > Ar,CO.GH(:WOH)R
HC1
was first described by Claisen and Manasse (123). Later studies by Slater 
(124) and Hartung and his associates (20,30,33,60) further showed that the 
oximinoketones could be successfully prepared in good yields by this scheme. 
This general nitrosation reaction was applied to the halogen, propiophenones 
in this investigation.
Only two of the oximino ketones prepared in this work,namely, p-chloro 
and p-bromo-otc-oximinoprophenone, have been previously described in the liter­
ature (20,65).
n-Butyl Nitrite
This ester, used as the nitrosating agent, was prepared by the method 
of Noyes (125) somewhat modified, according to the reaction:
2C4H9OH+2NaONO+H2S04------> 2C4H90H0+Na2S04+2H20
A 3 liter, 3-neck flask was fitted with a strong mechanical stirrer, 
a thermometer, and a dropping funnel leading to the bottom of the flask. 
Sodium nitrite (380 g. - 5.5 moles) was placed in the flask and 500 cc. of 
water and 1 Kg. of crushed ice were added. An ice-salt bath provided ex­
ternal cooling. Then 100 cc. of water, 136 cc. of conc. sulphuric acid 
(d 1.84) and 457 cc. (5 moles) of n-butyl alcohol were carefully mixed and 
cooled to 0°. This solution was then introduced below the surface of the
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nitrite wolution with stirring. Ice was added from time to time, as
necessary, to keep the mixture cold. Such addition of ice directly to the
reaction mixture decreased considerably the time required for the completion
of the reaction. The yellow nitrite which separated was removed, and the
aqueous salt solution, to which water was added, was allowed to stand for
about 1/E hour. Any nitrite which further separated was combined with the
previous portion. The total yield of ester was washed twice with 50 cc.
portions of a solution of 2 g. of sodium bicarbonate and £5 g. of sodium
chloride in 100 cc. of water, once with 50 cc. of water, dried over anhydrous
sodium sulphate, and filtered. The ester was distilled through a short
0column and the fraction boiling at 75-78 (atm.) was collected, n-Butyl 
nitrite was thus obtained as a yellow liquid in a yield of 402 g. (78%).
The nitrite was stored in a glass stoppered bottle in a refrigerator, 
and when it was more than 2 or 5 weeks old, it was redistilled before using.
General Nitrosation Procedure
The general procedure adopted for the preparation of the nine oxirnino- 
ketones obtained in this work by the reaction
Ar.C0.CH2.CH3 ---- 5H222---). Ar.C0.CH(:N0H)CH3
HC1
was similar to that used by Levin (126) and is as follows:
In a half-liter, three—neck, round bottom flask provided with a sealed 
mechanical stirrer, a reflux condenser connected to a gas-absorption trap, 
a delivery tube for hydrogen chloride, and a small dropping funnel was 
placed the halogen propiophenone dissolved in ether. The stirrer was set 
in motion and dry hydrogen chloride gas (generated by allowing conc. sul­
phuric acid to drop on conc. hydrochloric acid) was bubbled through the 
ether solution at the rate of about 2-4 bubbles per second; stirring and
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addition of acid was continued throughout the reaction. After the ether 
solution was saturated with hydrogen chloride (5-10 minutes), freshly distilled 
n—butyl nitrite was added by means of the dropping funnel in 0*5-1,0 cc, 
portions. After addition of the first portion the reaction mixture became 
orange brown, and after several minutes, a pale yellow* these color changes 
occurred after the a.ddition of each subsequent portion of nitrite. After 
the addition of the last several portions, the orange brown color remained. 
During the reaction the mixture gradually warmed up and the ether refluxed 
gently. After all of the nitrite had been added, stirring and the addition 
of the liyd.rogen chloride were continued for another 15 minutes.
The ether was removed by distillation from a water bath. When practically 
all the ether was gone, distillation was continued under reduced pressure 
to remove as completely as possible the butyl alcohol formed in the reaction. 
The crystalline oximino-ketone obtained was allowed to stand overnight in a 
vacuum desiccator over conc, sulphuric acid, and the crude product was then 
recrystallized from a suitable solvent.
n-Butyl nitrite was selected as the nitrosating agent in these experi­
ments since it is more conveniently handled and less likely to be carried 
out of the reaction mixture the hydrogen chloride than the more volatile 
nitrites. It was also chosen in preference to higher boiling nitrites, such 
as amyl nitrite since n-butyl alcohol formed during the reaction is more 
easily removed from the reaction product than the higher boiling amyl alcohol.
Ether, by virtue of its ready availability, low boiling point, and 
desirable solvent properties was found to be a very satisfactory nitrosating 
medium,
p-Fluor o-K.-oximinopr opi o phenone
p—Fluor opr op iophe no ne was nitrosated by the above general procedure
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using 45*6 g* (0*3 M) of the ketone in 300 cc* of ether and 34 g* (0*53 
moles) of butyl nitrite (added over 45 min*)* The crude yellow crystalline 
ox imino—ketone was re crystallized from toluene and yielded 59 g* of color­
less crystals. By extracting the mother liquor with 5%  sodium hydroxide, 
acidifying the extracts with hydrochloric acid, washing the precipitate with 
water and re crystallising from dilute alcohol (charcoal) an additional 9 g* 
of compound was obtained* Total yield of p-fluoro-o^-oximinopr opiophe none 
—  48 g* (88*4^), m.p* 106*5-7.5 • Nitrogen found—  7*70, 7.76^; calculated 
for CgH8FN02—  7.74$.
p-Chlor o-oC-oximinopr opiophe none
Edkins and Linnell (65) attempted unsuccessfully to prepare this com­
pound by adding a solution of butyl nitrite in alcohol and ether to a 
cold mixture of p-chloropropiophenone and sodium in absolute alcohol. The 
product which they isolated proved to be p-chlorobensoic acid. However, 
they were able to obtain the desired compound by treating a solution of 
p-chloropropiophenone, in ether, saturated with hydrogen chloride, with 
butyl nitrite. Their product was isolated as fine white needles from
odilute alcohol - m.p. 114 •
Bartung and co-workers (20) also obtained this oximinoketone by the 
nitrosation of p-chloropropiophenone in ether with butyl nitrite in a yield
of 8 3 m.p. 122—3 *
In this work, from 50.5 g. (0.3 moles) of plchloropropiophenone in 
300 cc. of ether and 34 g. (0.33 moles) of n-butyl nitrite (added over approx. 
45 minutes) was obtained by the general procedure, after recrystallization 
from 200 cc. of toluene, 47 g* of colorless crystals. In additional 6 g. 
of compound was obtained from the toluene mother liquor as described for 
.j-ke p-fluor*-compound. Total yield of p-chloro-oC- oximinopropiophenone
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53 g. (89.4$), m.p. 119-20°. Nitrogen found —  7.02,7.09$; calculated 
for C9 H8 C1N02  - 7.00$.
p-Bromo-cc-oximinopropiophenone
Edkins and Linnell (65) in their attempt to obtain this compound by 
nitrosating p—bromopropiophenone in alcohol, containing sodium, with butyl 
nitrite obtained only p—bromo*benzoic acid} in ether (saturated with hydrogen 
chloride) with butyl nitrite, they successfully obtained the oximino-ketone
Qas yellow-brown crystals from alcohol, m.p. 133.6 , in a yield of 82.5$.
In this work, from 63.9 g. (0.3 moles) of p-bromopropiophenone in 300 cc. 
of ether and 34 g. (0.33 moles) of n-butyl nitrite (added over approx. 45 
minutes, was obtained by the general procedure, after recrystallization 
from 225 cc. of toluene, 52 g. of colorless crystals. The mother liquor 
treated as described under the p-fluoro-compound yielded an additional 1 1  g.
Qof compound. Total yield 63 g. (8 6 .8 $), m.p. 132-33 • Nitrogen found —
5.61, 5.88$; calculated for C9 H8 BrN02 -5.79$.
m-Fluoro-<<-oximinopropiophenone
The crude yellow crystals obtained from 30*5 g. (0.2 moles) of m-fluoro- 
propiophenone in 300 cc. of ether and 22.7 g. (0.22 moles) of n-butyl nitrite 
(added over approx. 35-45 min.) was dissolved in 100 cc. of hot alcohol and 
decolorized with charcoal* From this alcoholic solution, after the addition 
of 130 cc. of water and cooling in a refrigerator, was obtained 29g. of 
of colorless crystals. An additional 2 g. was obtained by concentrating the 
mother liquor and recrystallizing the resulting crystals from benzene.
Total yield 31 g. (85.6$). Nitrogen found —  73.6, 7.64$; calculated for 
C9 HaFN02 -7.74$.
Tn-Chloro-oC-oximinopropiophenone
The crude yellow product obtained from 50.5 g. (0.3 moles) of m-chloro-
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propiophenone in 300 cc# of ether and 34g. (0*33 moles) of n-butyl nitrite 
(added over approx. 50 min.) was dissolved in 200 cc. of hot toluene and 
decolorized with charcoal. After concentrating the solution to about 2/3 
its original volume and cooling in a refrigerator, 4 4  g. of colorless crystals 
were obtained. An additional 5 g. of compound was obtained by concentrating 
the mother liquor, and recrystallizing the crystals obtained from dilute 
alcohol (charcoal). Total yield 49 g. (82.7%), m.p* 94-94.5 . Nitrogen 
found —  6.95, 6.94%; calculated for C9 H8 C1N02  —  7.00$.
m-Bromo-^-oximinopropiophe none
The yellow, crude product from 42 g. (0.2 moles) of m-bromopropiophenone 
in 300 cc. of ether and 22.7 g# (0.22 moles) of n-butyl nitrite (added over 
approx. 45-55 min.) was dissolved in 150 cc. of toluene and decolorized with 
charcoal. After concentrating the solution to 2/3 its original volume and 
cooling in a refrigerator, 51 g. of colorless crystals were obtained. On 
concentrating the filtrate further and recrystallizing the resulting crystals 
from 50% alcohol (charcoal), 6  g* more of compound was obtained. Total 
yield 57 g. (76.4%), m.p. 104.5-S r*. Nitrogen found —  5.71, 5.78%; calculated 
for C9 H8 BrN02  —  5.79%.
o-Fluor o-og-oximinopr o p iophe none
The crude product obtained by the general procedure from 13.0 g. (0.09
moles) of o-fluoropropiophenone in 1 0 0  cc. of ether and 10.5 g. (0 . 1  moles)
of n-butyl nitrite (added over 15-20 min.) was recrystallized from heptane.
o
A yield of 12 g. (73.6%) of slightly tan crystals, m.p. 82-82.5 , was ob­
tained. Nitrogen found —  7.71, 7.53%; calculated for C9 H8 FN02 -7.74%.
o-Chloro-q^oximinopropiophenone
The crude product obtained by the general procedure from 35.9 g. (0.2 
moles) of o-chloropropiophenone in 2 0 0  cc. of ether and 2 0 . 6  g. (0 . 2  moles)
of n-butyl nitrite (added over approx, 30 min,) was recrystallized from
0
heptane, A yield of 30 g. ( 7 6 % )  of colorless crystals, m.p. 102,5-105* as 
obtained. Nitrogen found 7.05, 6.87$; calculated for C9 H8 C1N02  —  7,00$.
o-Br omo-QC-oximinopr opiophe none
The crude product obtained by the general procedure from 38.5 g. (0.18
moles) of o-bromopropiophenone in 2 0 0  cc. of ether and 2 0 . 6  g. (0 . 2  moles) of
n-butyl nitrite (added over approx. 30 min.) was recrystallized from heptane.
o
A yield of 31 g. (71.1$) of colorless crystals, m.p. 101-101.5 , was obtained. 
Nitrogen found - 5.71, 5.72$J calculated for C9 H0 BrNOs-5.79$.
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IV# Catalytic Reduction of the Qximino—Ketones
The final phase of this investigation had as its object the reduction 
of the intermediate oximino-ketones to their corresponding primary amino— 
ale ohols (propadrines)*
Ar.C0#C(:N0H)CH3  — --^ > Ar*CHOH.CHHH2 .CH3
Prior to the work of Rosenmund and pfankuch (127), the catalytic re­
duction of oximes invariably resulted in a mixture of primary and secondary 
amines, with the latter sometimes predominating (128) • The production of 
the secondary bases may be explained tty the side reactions (129) :
(H) RpCHHHo (H) RpCTL
R2ONOH — ---- > R2C*-NH ^ R 2CHKHCHR2 —  —  j  2 ;HH+NHs
m 2  R2CH
These workers (R. and. p#) were the first to prevent the formation of secondary 
amine by their,use of the oxime acetate (benzaldoxime acetate)#
In a further study of this problem Hartung (108) was able to reduce 
benzaldoxime, with a palladinized-charcoal catalyst in absolute alcohol, 
to the primary amine without contaimination from the secondary base, by the
use of three equivalents of hydrogen chloride in the reduction mixture#
Applying these conditions to a series of oximino-ketones of the type 
Ar*C0.C(:N0H)R, where R=alkyl, Hartung and his associates (20,30,33,60) 
prepared the corresponding amino-alcohols in good yields#
Pd-charc oal
Ar.C0 #C(:N0H)R + H2— - > Ar#CH0H#CHNH2 *R(HC1)
(3HC1)
A summary of their studies (130) indicate that:
(1) Reduction of oximino-ketones In absolute alcoholic solution
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with a Pd—charcoal catalyst may follow one of two courses:
neutral Ar.CHOH.C(:NOH)R ♦ NH3  + mixed amines
/ sol* (slow hydrogenation)
Ar.CO.C(:NOH)R
3 equivalent Ar.CO. CHMi2 .R (HC1) ---> AR.CH0H.CHM2.R(HC1)
*  (rapid hydrogenation)HC1
(2) In the acid solution, reduction of oximino-ketones in which the 
aromatic portion is a hydrocarbon radical (i.e., phenyl, tolyl, naphthyl) 
goes smoothly and completely to the corresponding primary amino-alcohols.
(3) When the aromatic portion is substituted by a phenolic hydroxyl
or its methyl ether, reduction in acid stops at the amino-ketone stage. 
Further reduction to the amino alcohol may be accomplished in aqueous 
solution with a fresh catalyst, after isolation of the intermediate 
amino-ketone as its hydrochloride salt.
(4) The oximino group apparently is a readier receptor for hydrogen 
chloride, as is shown not only in the case of the phenolic derivatives, 
but also in some cases of *>-oximinopropiophenone when 2/3 of the cal­
culated hydrogen was taken up and the product proved to be the salt
of the amino-ketone, C6 H5 .C0 .CHNH2 .CH3  (HC1).
(5) The effect of hydrogen chloride is threefold:
a. Responsible for the hydrogenation of the oximino-group 
b* Marked effect on the rate of hydrogenation
c. prevents formation of contaminating secondary and tertiary bases. 
When the oximino-ketones contain a halogen substituted in the aromatic 
nucleus, an additional factor must be considered in their reduction, namely, 
the stability of the halogen to hydrogenation. Edkins and Linnell (65) 
studied the reduction of p-chloro and p-bromo-®^arainopropiophenone in an 
attempt to obtain compounds I ano. II.
CHOH.CHBHg.CH3  CHOH.CHBHg.CH3
(I) (XX)
Aluminum amalgam in acetic acid, sodium in acetic acid, and magnesium in 
methyl alcohol, all yielded products which resisted attempts at recrystal­
lization and which were nitrogen-free. Electrolytic reduction at different 
current densities produced no effect and the ketone was recovered unchanged* 
Attention was then directed to catalytic hydrogenation, but the re­
sults were again unfavorable. Hydrogenation in the cold in acid aqueous 
medium, with palladinized-charcoal as the catalyst, yielded phenylpropanol­
amine from both the p—chloro-and p-bromo-cfc-aminopropiophenones, Attempts 
to avoid this loss of halogen by varying the conditions of the experiment 
were unsuccessful.
Attempts were then made to prevent the loss of halogen by performing 
the experiments in acid alcoholic solution. Under these conditions the 
absorption of hydrogen was very slow and the products obtained in almost 
theoretical yields were the corresponding halogenobenzoic acids. It ap­
peared therefore that the reaction consisted of hydrolysis involving the 







In support of this contention they found that the reaction occurred equally 
well, though more slowly, in 97^ alcohol or in water in the presence of the
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catalyst, but in the absence of hydrogen. However, on shaking the amino- 
propiophenone with alcohol or water, without catalyst or hydrogen, only a 
trace of* acid was obtained. The presence of* catalyst therefore appeared to 
be essential.
The results of Hartung, Munch and Cross ley (SO) in the catalytic hy­
drogenation of p-chloro~fl(-oxiniinopropiophenone with a Pd-charcoal catalyst 
are not entirely in accord with those of Edkins and Linnell. In absolute 
alcoholic solution (containing three equiv. of HC1), the first S/3 of the 
requisite hydrogen was taken up quite readily and then the rate dropped 
markedly, and at this time a heavy crystalline precipitate had formed which 
was presumed to be the amino-ketone hydrochloride. To facilitate solution 
of the product water (which as a rule was employed without deleterious effect 
in reducing the amino-ketone to the amino-alcohol) was added, and the catalyst 
fortified by the addition of more PdClg, The rate of hydrogen absorption 
increased rapidly and proceeded until four equivalents had been taken up.
The product proved to be propadrine hydrochloride (C6 H5 .CH0H.CHNH3 ,CH3 -HC1).
In order not to reduce off the aromatic chlorine, it was found necessary to 
use large volumes of alcohol and to avoid the use of water.
Therefore in the catalytic hydrogenation experiments conducted in this 
investigation, it was necessary to employ conditions which would reduce the 
oximino and ketone groups but which would not result in the removal of the 
halogen from the benzene ring. These conditions are described under the 
individual compounds.
The following two catalysts were employed in the reductions.
Catalyst No*I was used in the initial reductions of the p-fluoro-oximino- 
ketone and was prepared as described under m-aminopropiophenone. In later 
experiments it was replaced by catalyst II which was more active.
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Catalyst No. II# Lovin (126) and Hartung and Reeve (131) have pointed 
out bhat the use of sodium acetate in the preparation of the palladium—char— 
coal produces a catalyst of Hhigh activity.w Therefore sodium acetate was 
employed in the preparation of this catalyst according to the folloY/ing 
procedure.
Palladium chloride crystals (0 . 6  g.) were dissolved with the aid of 
heat in 10 cc. of water and 5 cc* of conc# hydrochloric acid. This solution 
was added to 3 g. of Norite (E.K. and Co.) to form a paste to which was added 
90 cc. of water containing 12 g. of sodium acetate. This mixture was shaken 
in an atmosphere of hydrogen until saturated. Th® palladinized-charcoal was 
collected on a filter with suction, and washed thoroughly with distilled water 
and finally with absolute alcohol. The catalyst was kept under absolute al­
cohol, and was added to the reaction mixture as the alcoholic suspension 
(known concentration),
Reduction Mixture* This mixture was prepared by dissolving the oximino- 
ketone in absolute alcohol (commercial). Sufficient alcoholic hydrogen 
chloride to make the solution two normal in hydrogen chloride was added from 
a stock solution together with the alcoholic suspension of the catalyst. The 
mixture was then hydrogenated at approximately atmospheric pressure in an 
apparatus similar to that described by Hartung (108)•
The stock solution of alcoholic hydrogen chloride was prepared by pass­
ing dry hydrogen chloride gas into absolute alcohol (commercial), the alcohol 
being weighed before and after the passage of the gas to determine the con­
centration of the solution. It was stored in a glass stoppered bottle in 
the refrigerator.
Two tests were employed to determine the presence of any intermediate 
reduction product (amino-ketone) in the compound isolated from the hydrogenation.
1. Reduction of Fehling*s solution.. The pure ami no-alcohols do not
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reduce Fehling*s solution, but form with it a crystalline precipitate
ketone) reduces Fehlingts solution (30,60,65) with the formation of 
red copper oxide, and this fact as well as the measure of the hydrogen 
absorbed can be used in determining the completeness of the reduction# 
2. Pyrazine Formation# Amino-ketones of the type, R.C0.CHNH2 .R«, 
are unstable when liberated from their salts, undergoing spontaneous 
condensation to dihydropyrazines which are readily oxidized to the more 
stable pyrazine derivatives (£0,60,132,133)•
The characteristic color changes accompanying these reactions may be 
used as an indication of the presence of amino-ketone. When a solution 
of its hydrochloride is made basic (NaOH or KH4 0H), the solution be­
comes cloudy, turns yellow, and the dihydropyrazine gradually precipi­
tates as a bright yellow compound. On the addition of hydrochloric 
acid, the mixture assumes a fiery red color. The dihydropyrazine is 
converted to the more stable pyrazine on standing in the air, or more 
rapidly by the addition of mild oxidizing agents. The a mi no-alcohols, 
R-CH0 H.CHNH2  ,R?, ho?/ever are stable as the free bases and do not give 
the above reactions.
(60), On the other hand, the incompletely hydrogenated product (amino—
2 R.C0.CHMH2 .RI(HC1)— ^
E_C^ \3_Ri




In the initial experiments in which 5 g. (0.028 moles) of the oximino- 
ketone. in 100 cc, of 2N absolute alcoholic hydrogen chloride was hydrogenated
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with 5 g, of catalyst I, reduction ceased after only 1280 cc. of hydrogen 
(approx. 2 equiv. or 2/3 of the theoretical had been absorbed —  4 l/2 hours. 
At this point at which a crystalline precipitate (presumably the amino- 
ketone hydrochloride) was present in the reduction mixture, 50 cc. of dis­
tilled water was added to dissolve the precipitate, the catalyst was forti­
fied by the addition of 0*15 g. of palladium chloride, and hydrogenation 
continued. The final third equivalent of hydrogen was absorbed in 3 hours. 
The catalyst was filtered off, the filtrate placed over conc. sulphuric 
acid in a vacuum desiccator attached to a water pump, and the solvent re­
moved, The crude crystalline residue was dissolved in hot alcohol, the 
alcoholic solution cooled, and ether added. The fine colorless crystals
of p-fluoropropadrine hydrochloride, p-FCgB^.CHOH.CHMig.CJHgtHCl)> melted 
oat 222-3, gave no tests for amino-ketone, and on permanganate oxidation
produced p-fluorobenzoic acid. Yield 4 g. Nitrogen found —  6.61,6,75/bJ
calculated for C9 H1 3 N0FC1 - 6.82$.
In one run the product was isolated, after the reduction had ceased
at the 2 / 3  stage, and proved to be the amino-ketone hydrochloride, giving
oa dark red melt at 228-30 (dec.). Also, the use of water in the last phase 
of the hydrogenation did not cause the removal of the fluorine from the 
benzene ring.
In the subsequent reductions of this and the other compounds, using 
catalyst II, the relative rate of absorption of the first two equivalents 
of hydrogen was greater than in the above experiment. However, difficulty 
was experienced In completing the absorption of the third equivalent, in 
some cases heating of the reduction mixture with steam being necessary.
The procedure follows.
To a solution of 9 g. (0.05 moles) of the oximino-ketone in 200 cc. 
of 2N absolute alcoholic hydrogen chloride was added 2 g. of catalyst II,
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and the mixture hydrogenated. After 100 minutes, 2350 cc. of hydrogen 
had been absorbed (approx. 2  equiv. or 2 / 3  of theoretical) and the uptake 
hydrogen ceased. At this point 100 cc. of distilled water was added to 
dissolve the precipitate which had formed, together with 2  g. of fresh 
catalyst, and hydrogen uptake was resumed. It was necessary to heat the 
flask with a steam bath from time to time to complete the reduction, ap­
proximately sixteen hours being required for the absorption of the third 
equivalent of hydrogen.
The catalyst was filtered off and the solvent removed by distillation
ounder redxiced pressure using a water bath maintained at about 25-35 . The 
yellowish crystalline residue was dried over conc. sulfuric acid in a vac. 
desiccator, and washed thoroughly with ether to remove the color and any 
unreduced confound. The crude p-fluoropropadrine hydrochloride was purified 
as follows:
0A. Recrystallized from 70 cc. of absolute alcohol, m.p. 225-6
B. A few grams of crystals A recrystallized from absolute alcohol, 
m.p. 225-6°
C. Ether added to filtrate A - m.p. 221-2
D. Crystals C recrystallized from filtrate B + absolute alcohol, 
m.p. 225-6°
Total yield of p-fluoropropadrine hydrochloride - 8  g. (77.8%). Oxidation 
by permanganate gave p-fluorobenzoic acid, m.p. 183-3.5 after recryst. from 
hot water. Tests for amino-ketone were negative. Chlorine (as HCl). found—  
17.34, 17.19$; calculated for C0 H1 3 NOFC1 —  17.27%.
Reduction of m-fluoro-^-oximinopropiophenone
A solution of 9 g. (0.05 moles) of the oximino-ketone in 200 cc. of 
2N absolute alcoholic hydrogen chloride was hydrogenated, with 2 g. of cat­
alyst II. After 95 minutes, 2310 cc. of hydrogen (approx. two equiv. or
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2/3 of the theoretical) had been absorbed and the uptake of hydrogen ceased. 
One gram of fresh catalyst and 50 cc, of distilled water was added to the 
reduction mixture, and hydrogenation continued. An additional 1110 cc, of 
hydrogen was absorbed in about six hours*
The product was isolated as described for the para—compound, and the 
yellowish crude crystals washed thoroughly with ether, which removed most of 
the color. Purification was carried out as follows:
A. The crude crystals were dissolved in 70 cc. of hot absolute alcohol,
the solution filtered and cooled in the refrigerator. The colorless
o
crystals obtained melted at 210-10,5,
B. A few grams of crystals A were recrystallized from absolute alcohol, 
m.p, 210.5-11.
C. Ether was added to filtrate A, colorless crystals were obtained,
*m.p. 205-6.
oD. Product C was recrystallized from mother liquor B, m.p. 211-11,5.
E. All of the mother liquors were combined, evaporated to dryness on
a steam bath, and 1 0 % sodium hydroxide added to the yellow residue.
The liberated free amine was extracted with benzene, and the benzene
solution washed with water and dried over anhydrous sodium sulphate.
In p a s s i n g  dry hydrogen chloride into the solution, the hydrochloride
salt, m.p. 209-9,5 was obtained.
Total yield of m-fluoropropadrine hydrochloride, m-EC6 Ĥ .CH0H.CH]\SH2 .CH3 (HCl),
was 7 g. (6 8 %). The purified compound gave no tests for amino-ketone.
Chlorine (as HC1) found - 17.42,17.54%; calculated for C9H13W0FC1-17.27%.
o
Permanganate oxidation gave m—fluorobenzoic acid, m.p. 124—5. A mixed
o
melting point of this acid with pure benzoic acid was 112-13.
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Reduction of o-fluoro-OC-oxlminopropiophenone
A solution of 5*4 g* (0*05 moles) of the oximino-ketone in 150 cc. of 
2 N absolute alcoholic hydrogen chloride was hydrogenated, using 2  g. of 
catalyst II. After 105 minutes, 1500 cc. of hydrogen had been absorbed 
(approx 2/3 of theoretical) and the uptake of hydrogen ceased. At this 
point 50 cc. of distilled water and 1  g. of fresh catalyst was added to the 
reduction mixture and the hydrogenation continued. An additional 750 cc. 
was absorbed in about 4 hours.
The product was isolated as described for the p-fluoro-c ompound and 
thoroughly washed with ether. The almost colorless crystals were purified 
as follows:
A. The crude product was dissolved in 50 cc. of absolute alcohol, the
solution filtered, and cooled in the refrigerator. The fine color-
o
less crystals obtained melted at 251.5-2.5.
B. A few grains of product A was recrystallized from absolute alcohol,
o
m.p. 25 2 -2 .5«
o
C. Ether was added to filtrate Aj crystals obtained, m.p. 228-9.
D* Crystals C were recrystallized from the mother liquor of B,
m.p. 251-31.5.
The total yield of 0 “fluoropropadrine hydrochloride, o-FC6 H^.CH0H.CHNH3 .CH3 (HC1 
was 4 g. (65$). The purified compound gave no tests for amino-ketone.
Chlorine (as HCl) found - 17.32, 17.46$; calculated for C9 H1 3 N0FC1 - 17.27$.
o
Permanganate oxidation gave o-fluorobenzoic acid, m.p. 122-3 from heptane.
o
A mixed melting point of this acid with pure benzoic acid was 107-8.
Reduction of p-chloro-o^-oximinopropiophenoEe
In the light- of the experience of previous Investigators, the use of 
water in the final stage of the reduction of the chlorine substituted com-
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pounds was avoided*
A solution of 16.8 g. (0.085 moles) of the oximino-ketone in 500 cc* 
of 2 N absolute alcoholic hydrogen chloride was hydrogenated, using 3 g. 
of catalyst II. The hydrogen absorption ceased after about 3 hours at which 
time 3745 cc. of hydrogen (approx, 2/3 of the theoretical) had been taken 
up, and a heavy crystalline precipitate was present in the reduction mixture. 
The catalyst was fortified by the addition of 0*3 g. of palladium chloride, 
the reduction mixture heated with steam to about 7 5 , and shaking started.
The absorption of the third equivalent of hydrogen was slow and required 
about 17 1/2 hours, during which time it was necessary to heat the flask 
with steam from time to time.
The reduction product was isolated as described for the p-fluoro-com- 
pound and the crude yellow crystals were washed thoroughly with ether.
A. Recrystallization from absolute alcohol gave colorless crystals, 
m.p. 239-40?
9
B. Product A was recrystallized from absolute alcohol, m.p. - 244-5;
o
reported m.p. - 245 (20).
C. Ether was added to the combined mother liquors of A and B. The
o
colorless crystals obtained melted at 235-4,
o
D. Product C was recrystallized from absolute alcohol, m.p. - 243-4.
The total yield of p-chloropropadrine hydrochloride, p-ClCgH4j.CHOH.CH3 (HCl), 
was 15 g. (69%). The purified product gave no tests for amino-ketone. Chlo­
rine (as HCl) found - 16.23, 16.11%; calculated for C9 H1 2 N0C12  - 15.99%.
Permanganate oxidation produced p-chlorobenzoic acid,
Reduction of m-chloro~04-oximinonropiophenone
A solution of 10 g. (.05 moles) of the oximino-ketone in 500 cc. of 
2 N absolute alcoholic hydrogen chloride was hydrogenated, using 2  g. of 
catalyst II. After 2 hours, 2530 cc. of hydrogen (approx. 2/3 of the theo-
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retical) had been absorbed and "the absorption of hydrogen became very slow. 
One gram of fresh catalyst was added and the flaslc was heated with steam 
from time to time until the third equivalent had been taken up* this re­
quired an additional eight hours.
The product was isolated as before and the crude crystals obtained were 
washed with ether.
A* The crude crystals were dissolved in 40 cc. of hot absolute al­
cohol, filtered, ether added until the solution became cloudy, and 
the mixture cooled in the refrigerator. The colorless crystals
o
obtained melted at 180-181.
aB. Product A recrystallized from absolute alcohol, m.p. 185-184.
C. More ether was added to filtrate A, the colorless crystals obtained
°  °meltea at 160-2. Recrystallized from amyl alcohol, m.p. 181-2.
Total yield of im-chloropropadrine, m-ClC6 R^.GHOH*CHKH2 .CH3  (HCl), was 7 g. 
(63^). The purified product gave no tests for amino-ketone. Chlorine 
(as HCl) found - 16.13, 16.21^; calculated for CgH13N0Cl2-15.99$.
o
Permanganate oxidation gave m-chlorobenzoic acid, m.p. 154-4.5.
Reduction of o-chloro-<^oximinopropiophenone
A solution of 10 g. (0.05 moles) of the oximino-ketone in 400 cc. of 
2  N absolute alcoholic hydrogen chloride was hydrogenated, using 2  g. of 
catalyst II. After about 2 l/2 hours, 2420 cc. of hydrogen (approx. 2/3 
of the theoretical) was absorbed and the uptake of hydrogen was very slow.
An additional 1 g. of fresh catalyst ms added and reduction continued, 
heating with steam from time to time being required. The third equivalent 
of hydrogen was absorbed in about 17 l/ 2  hours.
After isolation as previously described and washing with ether the 
crystalline product weighing 9 g. was purified as follows:
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A# Recrystallized from absolute alcohol, m.p. 176-7 (dark brown melt) •
0B. Ether added to filtrate A, colorless crystals, m.p. 177-8 (dark 
melt)•
C# Products A and B combined and re crystallized from a equal mixture
oof ethanol and amyl alcohol, m.p. 182-5 (dark brown melt).
D# Ether added to mother liquor of C, crystals obtained melted at 182-5# 
The following facts concerning the above product were determined,
1. When an aqueous solution of the hydrochloride was made basic with
ammonium hydroxide the yellow color change characteristic of the
dihydropyrazine was produced. However, the addition of hydrochloric 
acid to the yellow mixture did not produce the fiery red color 
characteristic of the pyrazine reaction# For tliis reason the pyrazine 
reaction was not definite#
2. The compound reduced Fehlingis solution#
3# Permanganate oxidation gave a small amount of o-chlorobenzoic acid#
4# Analysis for chlorine (as HCl) showed 17#20%#
The hypothetical compounds which might be obtained by the absorption of 3
equivalents of hydrogen is indicated below:
1  equiv
1 equiv
C0.CHKH2 .CH3 (HC1) I 
19#13% Cl
Cl
CH0H.CHHH2 #CH3 (HC1) II 
15.99% Cl(as HCl)
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Although the evidence is insufficient to support a definite conclusion 
as to the structure of the reduction product, the assumption that it is 
a mixture of compounds X and II seems to agree with the data obtained#
Reduction of m-bromo-^-oximinopropiophenone
Using 2 g# of catalyst II, 12 g. (0*05 moles) of the oximlno-ketone 
was hydrogenated in 400 cc, of Z  N absolute alcoholic hydrogen chloride#
The first two equivalents of hydrogen were absorbed in about three hours.
To the mixture was then added 1 g# of fresh catalyst and hydrogenation con­
tinued, it being necessary to keep the mixture heated with a steam bath.
The third equivalent of hydrogen was absorbed in about six hours and the 
product was isolated and washed with ether. The crude crystalline product 
was recrystallized from 60 cc# of an equal mixture of sec .-butyl and amyl
alcohol and melted at 162-3^ A second recrystallization from sec.-butyl
oalcohol gave colorless crystals, ro#p# 164-5#
From the results of experiments conducted on the product, it was found 
that this product was not the desired m-bromo-propadrine hydrochloride#
On considering the following courses which the absorption of three equiva­




C0 #CHHH2 .CH3 (HX) I
CH0H-CHMH2 #CH3 (HC1) II
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it was concluded that the reduction had proceeded according to (I). This
conclusion was substantiated by the following evidence;
1* The production of benzoic acid, rather than m—bromobenzoic acid,
by permanganate oxidation of the product showed that the bromine
had been removed from the aromatic ring# The identity of the benzoic
acid obtained was verified by a mixed melting point with a sample of
known benzoic acid#
2# Tests for amino-ketone were positive# The yellow dihydropyrazine,
obtained by treating the reduction product with concentrated ammonia,
melted at 94-6 after recrystallization from dilute alcohol# Gabriel
o
(132) reported a melting point of 99 -100 for the dihydropyrazine 
which he obtained by the reaction;
C0*CHM2 .CH3 (HC1)
3# Quantitative analyses for halogen (as HX) indicated that the pro­
duct of the reduction was a mixture of the hydrochloride and hydro­
bromide salts# The presence of bromine (as HBr) was verified by 
checking the silver halide, obtained in the Volhard. analysis, 
qualitatively for bromide ion#
Therefore under the conditions of the hydrogenation used in this investi­
gation, it was not found possible to prevent the loss of bromine from the 
aromatic ring, and the desired m-bromo-compound was not obtained.
In view of this result, and that experienced with the o-chloro-compound, 
the reduction of the o— and p—bromo—oximino—ketones was not carried out#
This problem is reserved for future investigation when it is hoped that the 




(1) A literature survey correlating the relationship between molecular 
structure and physiological activity of the sympathomimetic amines is 
presented. The structures producing optimum physiological activity of 
these compounds is discussed.
(2) A literature survey of the pharmacology of propadrine is given together 
with a comparison of the physiological activities of its ring substi­
tuted derivatives.
(3) A literature survey of the physiological effects produced by the intro­
duction of halogens into the aromatic nucleus of pressor amines is also 
given.
(4) With the object of synthesizing a series of halogen ring substituted 
propadrines:
A. The following ketones were first prepared.
1. 0“
g, i- \  — fluoropropiophenone
3. p—
4. o-
5 . m-  ̂—  chloropropiophenone
6 . p-
7. o-
8 . m- V —  bromopropiophenone
9. p-
B. These ketones were converted into the following corresponding 












— bromo-oC-oximi noprop iophenone
Of these products (1 to 18) all except 1,6,7,8,9,15, and. 18 have not pre­
viously been reported.
C. Catalytic hydrogenation of compounds 10, 11, IS, 14, and 15 re­
sulted in the production of the desired halogen amino-alcohols (halogen 
propadrines), whereas in the case of compounds 13 and 17 reduction did 
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